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It was long believed that cytoplasmic events like translation and mRNA degradation are not 
linked to nuclear events such as pre-mRNA splicing. This view has been challenged in recent 
years by the discovery that pre-mRNA splicing can affect cytoplasmic processes such as 
nonsense-mediated mRNA decay (NMD). The current explanation is that this 
nucleus/cytoplasm communication is mediated by the exon junction complex (EJC), a 
multiprotein complex deposited during splicing in the nucleus and which remains associated 
with the mRNA during export to the cytoplasm. The consensus is that the EJC is deposited 
exclusively on spliced mRNA, 20-24 nucleotides upstream of the exon-exon junction. 
Splicing appears to deposit the EJC similarly in Drosophila melanogaster, yet it has also 
been reported that, in contrast to mammalian cells, the EJC might be required for splicing, 
suggestive of an earlier association with the pre-mRNA. The EJC appears to have an 
important role in the localization oskar mRNA to the posterior of the Drosophila oocyte. My 
PhD project aimed to visualize the assembly of the EJC on nascent RNA at polytene 
chromosome transcription sites. The main conclusion of these studies is that, contrary to 
current predictions, EJC components are recruited at transcription sites corresponding to both 
intron-containing and intron-less genes. A similar conclusion was reached in Drosophila S2 
cells, where chromatin immunoprecipitation coupled with high-throughput sequencing 
(ChIP-seq) data indicate that the core EJC protein Y14 associates to transcription sites 
independently of the gene having introns. Additionally, here I also report the results of two 
parallel projects aimed at testing whether ribosomal proteins and the NMD protein UPF1 also 
associate with Pol II transcription sites. My results confirm the presence of additional 
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1.1 Summary of eukaryotic gene expression  
Gene expression of protein-coding genes is a process in which genetic information contained 
in DNA is transcribed into messenger RNA (mRNA) which is then translated into protein. 
This process is different between eukaryotic and prokaryotic organisms. In prokaryotes, 
transcription and translation are a coupled process and transcripts start to translate during 
their transcription. However, eukaryotes possess a nuclear envelope which separates the 
transcription that occurs in the nucleus, from translation which takes place in the cytoplasm. 
Whilst within the nucleus, the primary transcripts (pre-mRNAs) must undergo post-
transcriptional modifications including 5’end capping, 3’end processing, and intron splicing 
(Figure 1.0). Following these processing the mature mRNA is then exported from the nucleus 
to the cytoplasm where it is translated by the ribosome. 
1.1.1 Pre-mRNA processing  
 
The first step of pre-mRNA processing is 5’ capping during which a guanine nucleotide is 
added to the 5’ end of pre-mRNA which is subsequently methylated to produce 7-
methylguanosine (m
7
G)  (Shuman, 2001).  This cap structure is recognized by the cap-
binding complex (CBC), consisting of two proteins, cap-binding protein 80 (CBP80) and 
CBP20. The 5’ cap protects the mRNA from 5’-3’ exonuclease degradation, thus playing an 
important role in mRNA stabilization (Beelman and Parker, 1995). The 3’ end processing 
reaction, which involves cleavage of the pre-mRNA and addition of a poly (A) tail at the 
3’end (Colgan and Manley, 1997), results in transcription termination and release of RNA 
Polymerase II (Pol II) from the DNA template. The majority of eukaryotic protein-coding 
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genes contain non-coding sequences, termed introns, that are removed from the primary 
transcript, in a process called splicing, to produce a functional mRNA. Segments of the pre-
mRNA that are retained in the mature mRNA are called exons. The splicing reaction is 
carried out by a large macromolecular complex, the spliceosome (Zhou et al., 2002). 
Additionally, transcripts of eukaryotic genes can undergo alternative splicing, which results 
in the production of different functional mRNAs  from a single pre-mRNA molecule (Berget 
et al., 2000). Therefore, alternative splicing has the potential to produce several protein 
variants from a single gene and is partly responsible for increased diversity of proteins in 
higher eukaryotes (Hui, 2009). Moreover, in eukaryotes, some of the RNA such as tRNA, 
rRNA, mRNA also undergoes RNA editing process (Su and Randau, 2011).  Although, RNA 
editing is rare compared to normal RNA processing as mentioned earlier, yet RNA editing 
responsible for great molecular diversity by addition, deletion or substitution of nucleotide 
bases within the RNA molecule.  
Once the processing of pre-mRNA is complete, mature mRNA is then exported from nucleus 
to the cytoplasm through the nuclear pore complex (NPC). By the time the mRNA is exported, 
it associates with several proteins to form an mRNA-protein complex (mRNP) – the formation 
of the mRNP starts cotranscriptionally, possibly with the binding of the CBC to the cap as it 
emerges from Pol II, it involves a large number of proteins and depends, as detailed in the 
sections below, on pre-mRNA processing.  The mRNPs undergo extensive remodelling as 
enter in the cytoplasm, yet some components which associated in the nucleus persist so that the 
structure and composition of the nuclear mRNPs influence downstream processes such as 









Figure 1.0 Schematic representation of eukaryotic gene expression. Gene expression in 
eukaryotes involves transcription of genomic DNA into pre-mRNA, which further undergoes 
several steps of processing, including 5’ capping, splicing, and 3’ polyadenylation, to produce 
mature RNA. Mature mRNA is then transported through the nuclear pore complex to the 







1.1.2 Coupling of transcription and pre-mRNA splicing 
 
Splicing is a multistep process catalysed by the spliceosome which consists of five small 
nuclear ribonucleoprotein complexes (snRNPs) each of which is composed of a small nuclear 
RNA (snRNA - U1, U2, U4, U5 or U6) and a number of associated proteins. Up to 300 
different proteins have been identified to be  associated  with the spliceosome (Nilsen, 2003).  
Some of these proteins are specific to a certain snRNP while others are present in all (Will 
and Luhrmann, 2001). The first step in splicing is recognition of the 5’ and 3’ splice sites 
(SS); this is mediated by the U1 and U2 snRNP U1 binds to the 5’end of the intron, while  U2  
associates with the adenosine in the pyrimidine rich region known as the branch point  (20-
50nt upstream of the 3’SS). This binding occurs in an ATP-dependent manner and, as a 
result, the pre-spliceosomal A complex is formed. Subsequent binding of U4, U5 and U6 
snRNPs as a tri-snRNP complex gives rise to the complex B or complete spliceosome 
(Sharma et al., 2008).  Further structural arrangements are required to form the catalytically 
active spliceosome (C complex) which includes dissociation of U1 and U4 (Figure 1.1). 
However, in metazoan the second type of intron with different splice sites recognized by the 
second class of U12 spliceosome or minor spliceosomes. The minor spliceosome consists of 
U11, U12, U4atac and U6atac which are functionally analog of U1, U2 and U4/U6 of the 
major spliceosome (Hall and Padgett, 1996). Although minor spliceosome contains U12 
snRNP instead of U2 snRNP, yet U12 dependent spliceosome follows the same splicing 
pathway as U2 dependent or major spliceosome. 
Although it was believed that pre-mRNA processing is independent from transcription, it is 
now clear that all these reactions are in fact coupled to this process. Most introns are spliced 
while the 3’ end of the pre-mRNA is still being synthesized by the RNA Pol II. Studies 
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performed by Carrillo Oesterreich (2010), using high-density tiling arrays for nascent RNA, 
indicate that splicing in yeast predominantly occurs co-transcriptionally. This is supported by 
additional chromatin immunoprecipitation (ChIP) experiments (Abruzzi et al., 2004; 
Gornemann et al., 2005). The carboxy-terminal domain (CTD) of RNA Pol II plays a key role 
in the coupling of splicing and other pre-mRNA processing reactions to transcription. The 
CTD serves as a platform for assembly of the pre-mRNA processing machinery and it is 
necessary for the efficiency of these processes (Phatnani and Greenleaf, 2006; Shatkin and 
Manley, 2000). The heptad repeats of Pol II CTD (26 in yeast and 52 in mammals) with the 
consensus sequence YS2PTS5PS7 undergo phosphorylation and dephosphorylation at several 
positions in such a way that enables RNA Pol II to associate with appropriate factors in 
different phases of the transcription cycle. Moreover, another in vitro study showed that CTD 
increases the rate of 5’ capping and 3’ end formation by functioning as a “landing pad” for 
processing factors, therefore facilitating their association with the nascent transcript or the 
correct assembly of these in multisubunit complexes (Carrillo Oesterreich et al., 2011; 
Perales and Bentley, 2009). One early study reported that deletion of CTD results in defects 
in 3’ end processing, splicing and transcription in human cells (McCracken et al., 1997). Co-
transcriptional splicing was first observed in Drosophila embryos by electron microscopy 
(Beyer and Osheim, 1988) as well as in further biochemical experiments in Drosophila 
salivary glands (LeMaire and Thummel, 1990). Moreover, an in vitro study in HeLa cells 
revealed that the assembly of the spliceosome on RNA Pol II transcript is proportional to the 
rate of its synthesis therefore,  immediate spliceosome assembly,  increased yields of spliced 
mRNA and  increase in the kinetics of splicing spliceosome (Das et al., 2006). Pol II 
elongation rate also appears to be a critical factor for co-transcriptional splicing, as mutation 
which induces lower Pol II elongation rate results in increased co-transcriptional splicing 
efficiency. In yeast and mammals, alternative splicing depends on the Pol II elongation rate 
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(de la Mata et al., 2010; Kadener et al., 2001). Also, it has been suggested that efficient 
cotranscriptional splicing may require a pause in Pol II elongation around the 3’SS 
(Alexander et al., 2010). Transcriptional pause release is recognized as an important step of 
gene expression regulation in mammals (Adelman and Lis, 2012). The transition from this 
paused state to elongation state requires the recruitment of positive transcription elongation 
factor b (P-TEFb), a cyclin-dependent kinase that is normally localized in an inhibitory 
complex containing 7SK noncoding RNA (Peterlin and Price, 2006). A recent report 
indicates that a splicing factor, specifically serine/arginine–rich splicing factor 2 (SRSF2), is 
a part of 7SK complex assembled at gene promoters and has a direct role in transcriptional 
pause release (Ji et al., 2013). Thus, the function of SRSF2 in transcription activation further 
indicates co-regulation of gene expression at both transcriptional and posttranscriptional 
levels in mammalian cells. SR proteins are a family of RNA-binding proteins that play an 
important role in splicing (Lin and Fu, 2007) and colocalize with 7SK in nuclear speckles, 
specific nuclear domains that are enriched in splicing factors. Additionally, previous studies 
have reported that a delay in transcript release may be required for complete processing in 
yeast (Schmid and Jensen, 2010).  
Recent studies of nascent transcripts in Drosophila indicate that fifty percent of introns are 
spliced co-transcriptionally, while the remaining ones are either poorly spliced or retained in 
the mature mRNA (Khodor et al., 2011). Co-transcriptional splicing also depends on factors 
such as intron length, intron number, exon length (Neugebauer, 2002). Several lines of 
evidence also suggest that the longer the gene is, the greater the chance of splicing of the 
nascent transcript (Beyer and Osheim, 1988).  In addition, a recent cotranscriptional  splicing 
study in mouse suggest that gene length and position strongly affects the efficiency of 




Figure 1.1 Schematic representation of co-transcriptional splicing. During transcription 
C-terminal domain of Pol II acts as a binding platform for several other proteins involved in 
pre-mRNA processing, splicing and export of mature mRNA. Pre-mRNA transcribed by Pol 
II associates with spliceosome components (U1, U2, U4, U5, and U6 snRNPs) in a step-wise 
manner so that introns are removed in a process called splicing. The first step involves the 
formation of complex A in which U1 and U2 are recruited to the 5’ splice site and the branch 
point A respectively. In the subsequent step recruitment of U4, U5 and U6 leads to the 
formation of complex B, which undergoes further rearrangements to form active complex C. 
These rearrangements cause two exons to ligate while intron is released in the form of a 
lariat. This figure was taken from Mandy S. Wong and Collaborators (2014). 
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1.2 Eukaryotic cell compartmentalization and the bridge between transcription and 
translation 
 
The distinctive feature of eukaryotic gene expression is that translation occurs only in the 
cytoplasm. However, coordination between transcription and translation is required to 
express genes accurately and efficiently. In case of prokaryotes, this is achieved directly, by 
physical coupling between the RNA polymerase and ribosomes which are loaded on the 
nascent transcript (Proshkin et al., 2010). Since in eukaryotes the nuclear envelope separates 
the nucleus from the cytoplasm, such direct coordination does not occur; transcription and 
RNA processing take place in the nucleus and translation in the cytoplasm. However, some 
studies indicate that pre-mRNA splicing, as a nuclear process, enhances cytoplasmic events 
such as nonsense mediated mRNA decay (NMD), outlined in the next section, which is 
coupled to translation (Carter et al., 1996). These studies suggest that there must be some 
means by which mRNAs that have been spliced are differentiated from otherwise identical 
transcripts generated from intron-less genes. The discovery of the exon junction complex 
(EJC), a number of proteins deposited on mRNA during splicing and transported along with 
it to the cytoplasm, provides an explanation. Next I will review the NMD phenomenon and 














1.2.1 Nonsense Mediated Decay (NMD)  
 
NMD is a translation dependent process found in all eukaryotes that rapidly destroys mRNA 
containing a premature translation termination codon (PTC) (Muhlemann et al., 2008).  NMD 
is thought to reduce the accumulation of proteins derived from PTC-containing mRNAs that 
could be detrimental to survival. NMD targets are originally identified as point mutations in 
the DNA which generated PTCs, but have since been found to arise from errors during 
transcription or pre- mRNA processing (Chang et al., 2007). NMD has been more intensely 
studied in Saccharomyces cerevisiae, D. melanogaster, Caenorhabditis elegans and 
mammalian cells (Amrani et al., 2004; Le Hir et al., 2001). All these studies indicate that 
NMD is an active process which requires mRNA translation and specific trans-acting factors. 
These include the up-frameshift proteins (UPF) encoded by the upf1, upf2, and upf3 genes, 
which were first discovered in a genetic suppressor screen in S. cerevisiae (Cummins et al., 
1980). A similar study also identified seven genes encoding NMD factors (SMG1-7) in C. 
elegans, The NMD factors UPF1, UPF2, and UPF3 are homologous to SMG-2, SMG-3 and 
SMG-4 in C. elegans. These three proteins are highly conserved in all eukaryotic organisms 
and deletion of one of these genes, particularly UPF1 or UPF2, result in stabilization of PTC-
containing mRNAs (Conti and Izaurralde, 2005; Perlick et al., 1996).  
UPF1 is considered to be the key component of NMD and current models suggest that it 
forms a surveillance complex by interacting with eukaryotic translation release factors (eRF1 
and eRF3) together with UPF2, UPF3 and exon junction complex (EJC) proteins to degrade 
PTC-containing mRNAs in the cytoplasm (Leeds et al., 1991). The UPF proteins associate 
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together to form an active complex which carries out NMD from yeast to humans (Conti and 
Izaurralde, 2005). However, a key outstanding question is how the cell distinguishes between 
those mRNAs that contain PTCs and those which possess normal stop codons. One model, 
known as faux 3’UTR model, predicts that this distinction depends on the distance between 
the stop codon and the 3’ end of the mRNA (Amrani et al., 2004; Behm-Ansmant et al., 
2007). The other model, as reviewed below, predicts that the PTC can be recognized by the 
presence of one or more downstream introns, which instead are typically not present in 
standard 3’UTRs. 
1.2.2 EJC stimulates NMD in mammalian cells  
Studies in mammalian cells indicate that a PTC is distinguished from a normal stop codon by 
its position relative to an exon-exon junction (Zhang et al., 1998). When a PTC is located 
more than 50-55 nucleotides upstream of last exon-exon junction the mRNA is targeted for 
rapid degradation (Zhang et al., 1998). This has been explained by the presence of EJC 
proteins, which are deposited on a spliced mRNA ~20-24 nucleotides (nt) upstream of the 
exon-exon junction; this binding is sequence independent, but position dependent (Figure 
1.2) (Le Hir et al., 2000a). This model provides a very plausible account of how splicing and 
NMD are linked. According to this model, during translation, when a ribosome reaches a stop 
codon upstream of the EJC, it serves as a binding platform for NMD factors which initiate 








Figure 1.2 Association of the EJC with spliced mRNA enables interaction with 
associated factors.  The EJC is deposited 20-24 nt upstream of an exon-exon junction during 
splicing. The EJC bound to a spliced mRNA creates a platform for other peripheral factors to 
assemble. Most of these factors are transiently associated with the EJC and their functions 
include NMD, mRNA transport, splicing, and mRNA localization.  This image was modified 





 Figure 1.3 The EJC forms a surveillance complex with NMD factors to degrade PTC-
containing mRNAs. During translation, the ribosome stalls at a PTC, allowing recruitment 
of UPF1 along with eRF1, eRF3, and SMG-1, forming the SURF complex. SURF then 
interacts with a downstream EJC, leading to SMG-1 mediated phosphorylation of UPF1 and 
further intecration with EJC-bound UPF2, leading to the formation of a surveillance complex, 





The EJC contains four proteins at its core: Y14 and MAGO, which form a heterodimer, 
eukaryotic translation initiation factor 4AIII (eIF4AIII) (Tange et al., 2004) and metastatic 
lymph node 51 (MLN51) (Barentsz or Btz in Drosophila) (Degot et al., 2004). These core 
EJC components allow it to interact in a dynamic manner with peripheral factors involved in 
splicing, mRNA localization, EJC assembly and the latter stages of mRNA metabolism 
(Figure 1.2). In the cytoplasm, apart from having a role in NMD, EJC components Y14, 
MAGO  and RNPS1, when tethered to an artificial reporter, enhance the translation yield 
from intronless mRNAs (Nott et al., 2004). In Xenopus oocytes, spliced mRNAs yield more 
protein than identical mRNAs produced from intronless genes. Thus, it has been concluded 
that splicing can enhance translation (Matsumoto et al., 1998).  
It has been proposed that eIF4AIII is the only component of the EJC in direct contact with the 
RNA, and it is with this that Y14 and MAGO interact before export to the cytoplasm (Ballut 
et al., 2005). eIF4AIII is a DEAD-box protein and belongs to the subgroup of DExH/D-box 
family of RNA-dependent ATPases, which bind to the RNA directly (Shibuya et al., 2004).  
The crystal structure of the three-dimensional core of the EJC explains how these 
components are organized into a complex (Bono et al., 2006). The structure of the EJC core 
is L- shaped with eIF4AIII and Btz at the base and the Y14-MAGO heterodimer arranged 
perpendicularly to it (Figure 1.4) (Bono et al., 2006). In the presence of ATP eIF4AIII adopts 
a closed conformation and binds to the RNA. Y14–MAGO forms a stable heterodimer with a 
molecular mass of about 40 kDa on spliced mRNAs and is considered to be a nuclear shuttle 
protein, which is imported back to the nucleus by Importin 13 (Imp13), a protein transport 
factor belonging the karyopherin-beta family (Bono et al., 2010). Although Y14 has an RNA 
recognition motif (RRM), its RNA binding site is buried when in association with MAGO 
(Fribourg et al., 2003). Thus, rather than binding to RNA, the main function of the Y14-
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MAGO heterodimer is to inhibit ATP hydrolysis of eIF4AIII, so that eIF4AIII effectively 
locks onto the RNA.  This explains the remarkable ability of the EJC to persist through 
nuclear export and cytoplasmic localisation (Ballut et al., 2005). As described above, the 
Y14-MAGO heterodimer has been shown to increase the translation of spliced mRNAs and 
both are also required for cell viability (Mohr et al., 2001). Additionally, a mutated form of 
Y14, which prevents its interaction with MAGO, leads to stabilization of NMD substrates. 
These observations suggest that Y14 and MAGO interaction is also crucial to elicit NMD 
(Kim et al., 2001).  
It has been  reported that eIF4AIII is recruited to the spliceosome during the early step of 
splicing rather than after splicing (Gehring et al., 2009). The mechanism of EJC loading 
during splicing was not clear until recent reports showed that the spliceosome component 
CWC22 interacts directly with eIF4AIII via a specific domain, which probably drives the 
splicing-dependent assembly of EJCs (Figure 1.5) (Barbosa et al., 2012; Steckelberg et al., 
2012). CWC22 is an abundant component of the activated spliceosomal C complex 






Figure 1.4 Three-dimensional representation of the arrangement of core EJC 
components. Human EJC seen here in two orientations rotated by 180⁰ about a vertical axis. 
In this model, Btz, marked in red, stretches over eIF4AIII (yellow). RNA (black line) 
interacts with two RecA-like domains of eIF4AIII. MAGO (in blue) and Y14 (in magenta) 
bind to domain 2 of eIF4AIII, and this interaction surface also included domain 1 of 
eIF4AIII. The dotted red line indicates the approximate position of a region of Btz not present 





Figure 1.5 The EJC component eIF4AIII is deposited during early steps of splicing. The 
interaction of the EJC core component eIF4AIII with splicing factor CWC22 creates a 
platform for other core factors, Y14 and MAGO, enabling their deposition on spliced 
mRNAs. Once the EJC has associated with spliced mRNA, it assists in guiding the mRNA 
through the nuclear pore complex to the cytoplasm. In the cytoplasm, the EJC has a role in 





1.2.3 Canonical and non-canonical form of EJC  
 
Previously, most research into the mammalian EJC was conducted, either in vitro or in vivo, 
with artificially tethered reporter RNAs or expressed proteins (Bono and Gehring., 2011). 
However, the most recent studies into endogenous EJC proteins show that in fact EJCs 
multimerize together with numerous SR proteins to form mega-Dalton sized complexes, in 
which SR proteins are super-stoichiometric to the EJCs core factors (Singh et al., 2012). 
These complexes, termed high molecular weight (HMW) EJCs, probably protect long 
stretches of RNA from nuclease digestion. Immunoprecipitation experiments confirmed the 
presence of the SRSF1, SRSF3, and SRSF7 SR proteins within the HMW complex.  In these 
studies, as expected, most of the EJC deposition sites were at the 24 nucleotide position 
upstream of the last exon-exon junction.  EJCs located in this position are termed canonical 
EJCs (cEJCs), however, recent  RNA seq  data indicate EJC binding is not always at such 
sites and enrichment is also found at other exonic locations, termed non-canonical EJC 
(ncEJC) sites (Singh et al., 2012). Unlike cEJCs, whose binding is sequence independent, 
ncEJCs are mainly observed to bind specific sequences including CG-rich motif regions in 
the first exon, C-rich motifs regions which resemble high affinity binding sites for SRSF3 in 
internal exons and AG-rich motif regions resembling the binding site for SRSF1 (Singh et al., 
2012).  
In a similar cross-linking immunoprecipitation (CLIP) study, which was followed by high-
throughput sequencing of eIF4AIII, one of the EJC’s core components was found to occupy 
both canonical and non-canonical regions  (Sauliere et al., 2012).  Remarkably, cEJCs and 
ncEJCs share similar features. There is no enrichment of either cEJCs or ncEJCs on the exons 
of intron-less mRNAs, while they are found in the CDS of spliced mRNAs and specifically 
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associated with exons flanked by long introns (Sauliere et al., 2012). Moreover, both CLIP-
seq and mRNA-seq data of two spliced mRNAs showed that eIF4AIII occupancy varies 
between the exon junctions from the same transcript, raising the question of whether other 
factors influence the presence of the EJC on spliced mRNAs (Sauliere et al., 2012). Analysis 
of the sequence motif region for eIF4AIII indicates enrichment associated with a GAAGA 
region at both canonical and non-canonical sites.  Interestingly, GAAGA regions are higher 
affinity binding sites for SR proteins. This observation suggests that the binding of the EJC is 
not uniform across exon-exon junction, as reported earlier.  In addition, the EJC forms a tight 
molecular bond with SR proteins, as previously reported in an in vitro study (Le Hir et al., 
2000b). Therefore, it is possible that SR proteins, or other RNA binding factors, directly or 
indirectly modulate the binding of the EJC to a particular site. 
1.2.4 The EJC is deposited at splice junctions also in Drosophila 
 
The EJC core proteins are well conserved in Drosophila; where Y14, MAGO and MLN51 
are also known as Tsunagi, Mago Nashi and Barentsz (BTZ) respectively (Macchi et al., 
2003; Mohr et al., 2001; Palacios et al., 2004). The core components eIF4AIII, Y14 and 
MAGO are mostly localized in the nucleus (Le Hir et al., 2001; Palacios et al., 2004). 
Although BTZ considered as a core EJC component, evidence suggests that BTZ associates 
with the EJC after mRNA export to the cytoplasm (Macchi et al., 2003). As described above 
eIF4AIII interact with splicing factor CWC22 and recruited early step of splicing, whereas 
MAGO and Y14 bind during excision of intron and exon ligation (Ballut et al., 2005).  
Association of BTZ  further stabilizes the EJC core on the mRNA in the cytoplasm (Bono 
and Gehring, 2011). A study into the Y14-MAGO heterodimer carried out in Drosophila, 
showed that it is required for the localization of oskar mRNA, a gene involved in Drosophila 
embryonic development, to the posterior pole of the oocyte (Hachet and Ephrussi, 2001). In 
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addition, mutant forms of either of the two proteins lead to mislocalization of oskar mRNA in 
Drosophila oocytes (Mohr et al., 2001). Recent findings reported that partner of Y14 and 
MAGO  (PYM), a cytoplasmic protein in Drosophila, enables the dissociation of the EJC 
from oskar mRNA, which leads to its mislocalization and female infertility (Ghosh et al., 
2014). Additionally, Y14 and MAGO are also required for germline stem cell differentiation 
and oocyte maturation (Parma et al., 2007). Unlike the mammalian heterodimer, Drosophila 
Y14-MAGO does not have any role in NMD (Gatfield et al., 2003). 
Although the majority of research focuses on the EJC’s role in post-splicing events, some 
recent data in Drosophila has shown that it could exist initially as a pre-EJC which influences 
the splicing process itself (Ashton-Beaucage et al., 2010; Roignant and Treisman, 2010).  
Evidence from these studies suggests that the pre-EJC plays an important role in splicing of a 
specific subset of primary transcripts, including mitogen activated protein kinases (MAPK) 
pre-mRNA, and in the absence of pre-EJC subunits, MAPK mRNA levels are significantly 
reduced. Based on their model, binding of the EJC occurs before splicing, and loss of the EJC 
from those sites results in exon skipping during splicing (Figure 1.6). This demonstrates 
another role for the EJC, that of influencing the processing of a specific set of transcripts in 
the nucleus. Moreover, it has also been proposed that pre-mRNA having large introns are 
more sensitive to depletion of pre-EJC,  which  result in exon exclusion indicates that the EJC 
has a role in exon definition of long intron-containing genes (Ashton-Beaucage et al., 2010). 
In a similar study it has been reported that the EJC is required for splicing of intron 4 of the 
piwi transcript, (a small non-coding RNA) and lack of the EJC results in splicing defects of 
this intron (Hayashi et al., 2014) . 
In summary, the EJC seems to have diverse functions, both in the nucleus and the cytoplasm, 
which further indicates that it plays an important role in coupling nuclear and cytoplasmic 








Figure 1.6 Pre-EJC dependent splicing. The EJC binds to pre-mRNA before splicing and 
aids in splice site selection. A lack of the pre-EJC from that site results in exon skipping. This 





1.3 Nuclear Translation 
1.3.1 PTC recognition in the nucleus   
                                                                                                                   
Although the EJC model provides a reasonable explanation of how splicing could affect 
NMD, and translation, other data from the NMD field indicate that PTC-containing mRNAs 
might also be degraded in the nucleus. Early studies suggest that many mammalian mRNAs 
are down-regulated by NMD in the nuclear fraction (Belgrader et al., 1994; Chang and Kan, 
1979; Urlaub et al., 1989). Additionally, it has also been reported that scanning of mRNA 
occurs either in the nucleus or when it is still associated with the nucleus before entering the 
cytoplasm (Maquat and Carmichael, 2001). Earlier evidence that nonsense mutations in the 
human triosephosphate isomerase (TPI) gene lead to the reduction of 25% of normal mRNA 
in the nucleus further support the suggestion that NMD is a nucleus-associated event 
(Belgrader et al., 1994). In addition, there is evidence from mammalian systems suggesting 
that NMD may take place in the nucleus (Chang and Kan, 1979).   
 The discovery of the cap binding complex (CBC) further supports the idea that NMD occurs 
on newly synthesized mammalian mRNAs. The cap binding complex (CBC) consists of the 
CBP20 and CBP80 subunits that bind to the 5’ cap of nascent mRNAs during transcription 
and are required for stability of the mRNA (Leeds et al., 1992). During the pioneer round of 
translation, CBP80 is replaced by cytoplasmic translation initiation factor eIF4E (Maquat et 
al., 2010). However, the study suggests that PTC recognition occurs while mRNA still bound 
with CBP80 before replace with cytoplasmic eIF4E, therefore NMD does occur with CBP80 
associated mRNA not with eIF4AE associated mRNA (Ishigaki et al., 2001). Therefore, 
CBP80-bound mRNAs harbouring a PTC are the primary targets of NMD, rather than eIF4E-
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bound mRNAs during the pioneer round of translation. In addition, NMD factors UPF2 and 
UPF3 are also observed to associate with spliced mRNPs when immunopurified with an anti-
CBP80 antibody (Ishigaki et al., 2001). However, this may suggest that nuclear NMD occurs 
during a pioneer round of translation of mRNAs which have not yet been released from the 
nuclear envelope. Moreover, in a parallel study it was also reported that EJC components co-
immunopurified with CBP80 but not with eIF4E (Lejeune et al., 2002). In addition, it is also 
reported that the level of mRNAs bound by the CBP80 subunit decreases in the presence of 
PTC. In contrast, there is no such decrease in mRNA levels observed when bound by eIF4E, 
further indicating that NMD acts only on CBP80-bound mRNAs (Cui et al., 1995).  
However, it is also proposed that PTC recognition occurs on nascent transcript and this idea is 
supported by experiments showing that PTCs can affect specific nuclear events, such as 
alternative splicing and 3’ end formation (Brogna, 1999; Wang et al., 2002) . Moreover, a ChIP 
study indicated that SMG6 and UPF1 associate with transcription sites of both PTC+ and PTC– 
reporter genes in mammalian cells, suggesting that NMD may occur co-transcriptionally (de 
Turris et al., 2011). Taken together, the evidence suggests that PTC recognition, and therefore 
translation, might also occur in the nucleus, possibly close to sites of pre-mRNA synthesis. 
1.3.2 Controversial issue with nuclear translation 
 
The hypothesis that some translation occurs in the nucleus remains debated. The debate has 
been re-opened following the observation that some NMD also occurs in the nucleus. Thus, it 
has been proposed that NMD mechanism utilizes active nuclear ribosomes (Wilkinson and 
Shyu, 2002). More recently, direct evidence for nuclear translation was provided by 
experiments that allow visualization of translation sites in mammalian cells (Iborra et al., 
2001). It was reported that fluorescently labelled amino acids could be incorporated into 
nascent peptides in highly purified nuclei. In this assay, putative translation sites were readily 
23 
 
visible under a fluorescence microscope and appeared as distinct fluorescent dots. The 
occurrence of this nuclear fluorescence was prevented by translation inhibitor drugs. 
In Drosophila, similar observations were reported and found that [35S] methionine/cysteine 
was rapidly incorporated at active transcription sites of polytene chromosomes and also in the 
nucleolus; this incorporation is sensitive to translation inhibitor drugs (Brogna et al., 2002). In 
addition, many ribosomal proteins and some translation factors are found associated with 
transcription sites, and an in-situ hybridization study showed that rRNAs are also present at 
these chromosomal sites (Brogna et al., 2002). It was argued, that the nuclear translation 
reported by Iborra et al (2001) may be an artefact of over-permeabilization that allowed entry 
of cytoplasmic ribosomes into the nucleus (Nathanson et al., 2003). Additionally, it was also 
argued that the antibodies used by Brogna et al to detect ribosomal proteins were not 
sufficiently specific. However, one study in yeast suggests that ribosomal proteins also present 
at chromosomal sites (De et al., 2011; Schroder and Moore, 2005). In addition, fluorescent 
protein tagging recently confirmed the presence of ribosomal proteins at Drosophila polytene 
chromosomes (Rugjee et al., 2013). This further observation is consistent with previous 
observations made by Brogna et al (2002).  Furthermore, it has very recently been reported that 
puromycin can be incorporated into the nucleus and nucleolus of mammalian cells, and it was 
concluded that translation therefore must occur at these sites (David et al., 2012). In this study, 
they developed a novel technique known as ribopuromycylation in which the usually released 
puromycylated peptide is immobilized on ribosome by translation elongation inhibitor drugs, 
followed by detection of these nascent chains with an antibody specific to puromycin. It has 
however been argued that puromycylation is an indicator of peptidyl transferase activity, and 
not necessarily of 80S engaged in translation (Dahlberg and Lund, 2012). The question of 




1.0 Aims, and research plan 
 
I would like to advance our understanding of the mechanism that links pre-mRNA splicing 
with NMD. The results of a number of studies across organisms show that pre-mRNA 
splicing, a strictly nuclear process, affects NMD, a process expected to be restricted to the 
cytoplasm. It has been proposed that this link is mediated by the exon junction complex 
(EJC), a multiprotein complex deposited during splicing in the nucleus, which remains 
associated with the mRNA during export to the cytoplasm. Some observations are not 
consistent with this function attributed to the EJC. For example, all of the proteins that 
constitute the EJC are well conserved in Drosophila, yet these proteins are not required for 
NMD in this organism. Since splicing is a co-transcriptional process in Drosophila,  
 I aimed to visualize the association of EJC proteins at the sites of transcription at 
which nascent RNA is present, in the polytene chromosome. If these proteins do 
associate with transcription sites, I will then directly test key predictions of current 
models such as that EJC proteins are recruited selectively at intron-containing genes 
and will also assess whether EJC assembly differs depending on specific intron 
features.  
 In my second project I will investigate whether there are functional ribosomes and 
ribosomal proteins at transcription sites and whether there is a link between these 
ribosomes and NMD. I plan to investigate the presence of both ribosomes and 
ribosomal proteins at transcription sites by using the same approach as used for EJC 
proteins. In parallel, I will use a similar experimental approach to visualize nascent 
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RNPs and pre-mRNA splicing at the site of transcription, which will give us a better 





2.0 Materials and Methods  
2.1 Solutions and buffers  
 
All buffers, solutions, and media were prepared according to standard protocols described in 
Molecular Cloning 4th edition (Sambrook et al., 2012). Molecular biology kits were used as 
directed by the company, unless otherwise stated. All solutions were prepared with analytical 
grade reagents (Sigma-Aldrich, Fisher Scientific or VWR) in double distilled water and 
subsequently sterilized by autoclaving or by filtration through a 0.22 µm filter (Pall 
Corporations). Solutions used for RNA experiments were treated with diethylpyrocarbonate 
(DEPC, 0.1% v/v), incubated overnight in a laminar flow hood and subsequently sterilized by 
autoclaving the next morning. 
2.2 Drosophila Schneider 2 cells (S2 cells) culture and maintenance 
The S2 cell line derives from a primary culture of late stage (20-24 h old) Drosophila 
melanogaster embryos (Schneider, 1972).  S2 cells are easy to maintain as they normally 
grow at room temperature without CO2 and form a semi-adherent monolayer in tissue culture 
flasks. S2 cells were maintained in T25 tissue culture flasks in Insect–XPRESS medium 
(Lonza) supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) Penicillin-
Streptomycin-Glutamine (P/S/G) (Invitrogen), incubated at 27°C without CO2. S2 cells were 
normally split in a 1:5 ratio of cells to media into a fresh tissue culture flask every two days 





2.2.1 Transfection of S2 cells  
 
 To carry out transfection, cells were seeded at a 3 X 10
6
 cells/well in a 6 well plate with 
complete media (10% v/v FBS and 1% v/v P/S/G) and were grown at 27⁰C. The following 
day, transfection was carried out by mixing plasmid DNA (2.5 µg/ml per well) with 5µl of 4 
mg/ml of the transfection reagent dimethyldioctadecylammoniumbromide (DDAB, Sigma-
Aldrich) as described in Ramanathan and collaborators (2008). DNA was thoroughly mixed 
with DDAB and incubated for 30 min at room temperature. Meanwhile, cells were washed 
twice with 1 ml serum-free media (no FBS and P/S/G). Following incubation, the whole 
transfection mix was diluted with serum-free media to a final volume of 1 ml shaken 
vigorously to ensure thorough mixing, then transferred into the well of the cell culture plate. 
The cell culture plates were kept in the 27⁰C incubator for 2 h and 30 min. After incubation, 
the transfection mix was carefully removed from the well and replaced with 2 ml 10% (v/v) 
complete media (10% v/v FBS and 1% v/v P/S/G,) and returned it is only similar with those 
with to 27⁰C incubator for a further two days. 
2.3 Chromatin Immunoprecipitation (S2 cells) 
2.3.1 Cross-linking and sonication  
  
S2 cells were grown in a T75 tissue culture flask at 27°C in 15 ml of Insect–XPRESS 
medium (Lonza) supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% v/v P/S/G 
(Invitrogen) for 2 days. The cells were counted with a haemocytometer and 10
7
 cells were 
used for each ChIP. Cells were fixed by adding formaldehyde (10% EM grade, Polyscience) 
to a final concentration of 1% (v/v) and incubated at 25°C for 15 min. After fixation, glycine 
was added to the cell mixture at a concentration of 125mM, followed by incubation another 5 
min at 25°C to stop the cross-linking reaction. Next the cells were pelleted by centrifugation 
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at 3000 rpm/ 835 g (Eppendorf) for 5 min at 4⁰C. The cell pellet was resuspended in 500 µl 
of 1X PBS with one tablet of EDTA-free Complete Protease Inhibitor Cocktail (Roche) and 
washed for two times. After washing, the supernatant was discarded, and cell pellets were 
stored at -80°C for further used in a ChIP experiment. 
 
2.3.2 Sonication optimization 
Sonication is one of the key steps for successful ChIP as it renders the chromatin soluble and 
dictates the resolution of the assay. Normally the DNA fragment size used in a ChIP 
experiment is 200 – 1000 bp. Sonication conditions should be optimized for different cell 
lines, and the sonication efficiency depends on the cell line, cell density, and the extent of 
cross-linking. Sonication was performed with Biorupture (Diagenode). Conditions were 
optimized using S2 cells with different time intervals and a pulse of 15 seconds on and 15 
seconds off, to produce DNA fragments in the range of 0.5-1.0 kb in size. The fragment sizes 
were checked by agarose gel electrophoresis (Figure 2.1). Judging from the gel, sonication 
carried out between 8 and 16 minutes produced the desired sized fragments. Therefore, 







Figure 2.1 Optimization of sonication time 
Sonication of chromatin samples for different time intervals (2 min, 4 min, 8 min and 16 min) 
using a Biorupture sonicator. The samples were run on a 1% agarose gel (w/v), and the size 
of the fragment was determined by comparison with a 100 bp DNA marker (Thermo 




2.3.3 Chromatin immunoprecipitation 
 
ChIP was performed using 40 µL of Dynabeads®Protein-G beads, per sample.  The 40µL of 
beads was split into two tubes, 25µL of which were coated with the desired antibody (+Ab) 
and 15 µL of which were pre-absorbed (-Ab). The beads were then washed four times in 
LoBind microcentrifuge tubes (Eppendorf) with 1ml of 1X PBS containing 5 mg/ml bovine 
serum albumin (BSA). Washing steps were carried out by rotating the tubes six times in a 
magnetic stand.  After each wash the beads were allowed to migrate to the back of the 
magnetic stand so that the supernatant could be discarded completely. 
After the final wash, beads were resuspended again in 500 µL of 1 X PBS with 5mg/ml BSA. 
Typically, 2µg of anti-Y14 antibody (see section 2.8.10) were added to the tube derived from 
25 µL of beads. Both +Ab and –Ab tubes were incubated overnight at 4⁰C with rotation. The 
next day pellets of cross-linked cells (section 2.3.1) were thawed on ice and resuspended in 
100 µl of SDS lysis buffer (1% w/v SDS, 10 mM EDTA). The cell suspension was then 
sonicated at high intensity for 12 min with 15 sec on/off in a Bioruptor sonicator. Samples 
were diluted in 1 ml ChIP dilution buffer (0.01% w/v Sodium dodecyl sulfate (SDS), 1.1% 
v/v Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl) and centrifuged 
at 13000 rpm/ 15682 g (Eppendorf) for 10 min at 18°C (n.b. SDS will precipitate at 4⁰C) to 
pellet insoluble material. The supernatant (soluble chromatin) was kept in LoBind 
microcentrifuge tubes at 4⁰C. In the meantime, both +Ab and -Ab beads were washed four 
times with 1 ml of 1 X PBS with 5mg/ml BSA to remove unbound antibody, using a 
magnetic stand as before. +Ab beads were then resuspended in 40 µl of 1X PBS with 5mg/ml 
BSA, whereas -Ab beads were resuspended in 25 µL and added to prepared before. Next 1 ml 
of the soluble chromatin was added to the -Ab beads and incubated for 15 min at room 
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temperature with rotation.  The mixture was then spun briefly, the beads were pelleted in a 
magnetic stand and the supernatant was transferred into a fresh LoBind microcentrifuge tube. 
Approximately 50-100µL of the soluble chromatin was kept as an input control and stored at 
-20°C. The 40µL+Ab beads sample was added to the remainder of the soluble chromatin and 
incubated for two and a half hours at room temperature with rotation to allow the formation 
of antibody-antigen immune complexes on the beads. 
2.3.4 Washing steps 
 
The beads were separated from the supernatant using a magnetic stand, as previously 
explained. Beads were then sequentially washed with rotation at room temperature for 5 min 
with 1 ml of each of the following buffers: low salt wash (0.1% w/v SDS, 1% v/v Triton X-
100, 2 mM EDTA, 20 mM Tris-HCL pH 8.1, 150 mM NaCl); high salt wash (0.1% w/v SDS, 
1% v/v Triton X-100, 2 mM EDTA, 20 mM Tris-HCL pH 8.1, 500 mM NaCl); LiCl wash 
(0.25M LiCl, 1% v/v IGEPAL-CA630, 1% w/v deoxycholic acid, 1 mM EDTA, 10 mM Tris-
HCL (pH 8.1); two 5 min washes in 1mL of TE buffer (10 mM Tris-HCL (pH 8.0), 1 mM 
EDTA). Beads were vortexed in each washing buffer and collecting on a magnetic stand, as 
previously described.  The supernatant was discarded after each wash. 
2.3.5 Elution steps and reverse cross-links 
 
Protein-DNA complexes were eluted from the beads by washing them twice with 75µl of 
freshly prepared 0.1M NaHC03 solution containing 1% w/v SDS. The mix was then vortexed, 
briefly spun and incubated with rotation at a room temperature for 15 min. The tube was spun 
briefly and the beads were separated from the supernatant using a magnetic stand. The 
supernatant was transferred to a new LoBind microcentrifuge tube and the beads were 
resuspended with a further 75 µl of elution buffer and the process was repeated, resulting in a 
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final volume of 150 µl. More elution buffer was added to the input sample to bring it up to 
the same volume as the ChIP sample (150 µl). Protease K was added to all samples (2 µl of 
50 mg/ml) which were then incubated overnight at 65⁰C on a dry heat block to digest 
proteins and to reverse crosslinks. 
2.3.6 Purification steps 
 Following overnight incubation, DNA samples (both the input and ChIP samples) were 
purified using AMPure XP beads (Beckman Coulter). 1.8 volumes of AMPure XP bead 
slurry was added to each DNA sample. Samples were mixed by vortexing thoroughly and 
were incubated with rotation for 10 min at room temperature to allow the DNA to bind to the 
beads. Once the incubation was completed, samples were briefly spun, and beads were 
recovered using a magnetic stand while the supernatant was discarded. Beads were then 
washed three times with 300 µL of freshly prepared 70% v/v ethanol (EtOH), using a 
magnetic stand as previously described, ensuring all EtOH was removed. The pellet was air-
dried in a magnetic stand until cracks were visible in the beads slurry. DNA was eluted by 
resuspending the beads in 30µL of 10 mM Tris elution buffer (pH 8.0). The tube was placed 
back into the magnetic stand to separate the beads from the eluate. This process was repeated 
three times until all the beads were removed.  
2.3.7 Solid ChIP-Seq library preparation  
 
Library preparation and sequencing of ChIP DNA were performed by Dr. Paul Badenhorst at 
the Institute of Biomedical Research (IBR), University of Birmingham, UK, using the SOLID 





2.4 S2 cells RNA interference (RNAi) 
 
A primer pair for the gene of interest was obtained from an online tool - fly RNAi Updated 
Targets of RNAi Reagents (UP-TORR) - www.flyrnai.org/up-torr, and the desired gene Y14 
and eIF4AIII was PCR amplified from FLAG-tagged plasmid (Appendix IV) and MAGO 
from fly cDNA plasmid library (available in Dr. Brogna lab). PCR fragments were purified 
with a QIAquick PCR Purification Kit (QIAGEN) according to the provided protocol. All the 
primer pairs used were tagged with the T7 promoter sequence (5’-
TTAATACGACTCACTATAGGGGAGA-3’) at the 5’ end. The dsRNAs were synthesized 
using the T7 RiboMAX express RNAi system (Promega) according to the manufacturer’s 
instructions: 1µg of DNA was used as a template in a 20µl reaction containing 10µl 
RiboMAX Express T7 2X buffer and 2µl Enzyme Mix T7 express. The final volume was 
adjusted to 20µl with diethylpyrocarbonate (DEPC) treated water. The tube was gently mixed 
and incubated for 2 h at 37⁰C. The mix was then incubated for 20 min at 70⁰C in a dry 
heating block to inactivate the enzyme and to allow the RNA strands to anneal. 1µl of DNase 
I (Promega) was added to the mix to remove the DNA template and the sample was further 
incubated for 30 min at 37⁰C. 
2.4.1 Purifying dsRNA  
 
To purify dsRNA, 2.5 volumes of 95% v/v EtOH and 0.1 volumes of 3M sodium acetate (pH 
5.2) were added to the mix and incubated for 30 min at -20⁰C. The RNA was then pelleted by 
centrifugation at 13,000 rpm/ 15682 g (Eppendorf) for 15 min at 4⁰C, and the supernatant 
was discarded. The pellet was washed in 70% v/v EtOH and air dried for 15 min at room 
temperature, then resuspended in 100µl of DEPC treated water. Nanodrop spectrophotometer 
was used to measure the concentration of dsRNA, and its integrity was checked by running 




2.4.2 S2 cells siRNA 
 
S2 cells were grown for two days in T25 culture flasks with 5 ml of Insect–XPRESS medium 
(Lonza) supplemented with 10% v/v fetal bovine serum (FBS) and 1% v/v P/S/G (Invitrogen) 
media. On the day of the RNAi treatment, cells confluency were checked by phase contrast 
microscopy and subsequently transferred into a 50 ml falcon tube. The cell culture was then 
centrifuged at 1000 rpm/ 92 g (Eppendorf) for 3 min at room temperature, the supernatant 
was discarded and the cell pellet was diluted with serum-free media (without FBS and P/S/G) 
to a final concentration of 10
6
 cells/ml. Next 1 ml of cell culture was transferred to each well 
of a six-well cell culture plate and 15µg of dsRNA was added to each. The cell culture and 
dsRNA were mixed by moving the plate back and forth several times and were incubated for 
a further hour at room temperature. After incubation, 2 ml of complete media (10% v/v FBS 
and 1% v/v P/S/G) was added to the plate, mixed and placed in the 27⁰C incubator. The plate 
was then incubated for a further four days to allow depletion of the pre-existing targeted 
protein. After four days, cells were treated with 1µM ecdysone without changing the media 
and incubated for 2 h at room temperature. RNA was then extracted from all the samples. 
2.4.3 RNA extraction and complementary DNA synthesis (cDNA) 
 
RNA extraction from S2 cells was carried out using the RNeasy Mini Kit (QIAGEN) 
according to the manufacturer’s instructions. 700ng of total RNA was used for cDNA 






2.4.4 Quantitative Real-Time PCR 
 
Quantitative real-time PCR was carried out using the SensiFAST SYBR Hi-ROX Kit 
(Bioline). Real-time PCR was carried out in 96 well plates in an Applied Biosystems Prism 
(ABI PRISM) 7000. The qPCR reaction was a two-step cycle with an initial denaturation at 
95⁰C for 2 min, followed by 40 cycles of denaturation at 95⁰C for 15 s and annealing and 
extension at 60⁰C for 1 min. The primer pairs used to check transcript levels of various genes 
are listed in Appendix II. The threshold cycle (Ct) was set at a point where all samples were 
in the exponential stage of amplification. This value was used to measure transcript levels of 
target genes and was normalized by dividing by the level of the reference RpL32 control 
transcript for each sample.  
2.5 Purification of nuclear and cytoplasmic fractions from S2 cells 
 
To separate nuclear and cytoplasmic fractions, a protocol based on one published by Parker 
and Topol (1984) was used. S2 cells were grown in a T75 tissue culture flask at 27°C in 15 
ml of Insect – XPRESS medium (Lonza) supplemented with 10% v/v fetal bovine serum 
(FBS) and 1% v/v penicillin/streptomycin/glutamine mix (Invitrogen) for 2 days. Cells were 
then pelleted by centrifugation at 2500 rpm/ 580 g (Eppendorf) at for 5 min and washed with 
ice cold PBS twice (a 1 ml aliquot of the culture was pelleted and kept as whole cell extract). 
The cell pellet was resuspended in five times its volume in buffer A (15 mM KCL, 10 mM 
HEPES (pH 7.6), 2mM MgCl2, 0.1 mM EDTA) and was centrifuged at 5000 rpm/ 2319 g 
(Eppendorf) for 5 min at 4⁰C. Supernatant was discarded, and the pellet was resuspended in 
the same volume of buffer A with the addition of DTT to the concentration of 1mM. The 
cells were then homogenized using a Dounce glass homogenizer (a 2 ml homogenizer with a 
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tight (B) pestle) and checked under a phase contrast microscope to confirm that at least 85% 
of the cells were broken. The cell suspension was then mixed with 1/10 volume of buffer B (1 
M KCl, 50 mM HEPES (pH 7.6), 30mM MgCl2, 0.1mM EDTA, 1mM DTT) and centrifuged 
at 10000 rpm/ 9279 g (Eppendorf) at 4⁰C or 10 min. After centrifugation the supernatant was 
kept as a cytoplasmic fraction (1ml) and the pellet was considered a crude nuclear extract 
which was dissolved in 400µl of 9 parts buffer A and 1part buffer B. 100µl of the crude 
nuclear extract was transferred to a new tube and 4 M ammonium sulfate (pH 7.9) was added 
to the remainder at a final concentration of 0.36 M. The mix was gently rotated at 4⁰C for 30 
min to lyse the nuclei and then centrifuged at 16000 rpm/ 23755 g (Eppendorf) at 4⁰C for 1h 
30 min to pellet the DNA. To the supernatant ammonium sulfate was added at 0.25 g/ml, 
followed by centrifugation at 16000/ 23755 g (Eppendorf) rpm for 15 min at 4⁰C and pellet 
was kept as soluble precipitated protein.  
2.6 S2 cells and salivary glands Western blotting 
2.6.1 Sample preparation 
  
Salivary glands (20-30 pairs) were dissected from mid-3rd instar larvae in Shields and Sang 
M3 insect medium consist of inorganic salt, amino acid, vitamins, sugar and yeast extract 
(Sigma-Aldrich). All glands were then transferred to 2x SDS loading dye supplemented with 
5% v/v β-mercaptoethanol and 1mM PMSF and homogenized with a plastic pestle grinder in 
a 2ml microcentrifuge tube. The lysate was boiled for 6 min in a heat block which was 
followed by cooling for 1 min on ice. Samples were centrifuged at the highest speed at 4⁰C 
for 2 min in a microcentrifuge and either loaded on SDS-PAGE gels or stored at -20⁰C. 
S2 cells were grown in six-well plates to a density of 3x10
6
 cells/ml, as described above 
(section 2.2.1). 1 ml of cells was collected in a 1.5 ml microcentrifuge tube and centrifuged at 
5000 rpm/ 2319 g (Eppendorf) at 4⁰C for 3 min. Cells were washed twice with 500 µl of ice-
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cold PBS and the pellet was dissolved in 100 µl of 2X SDS loading dye. Samples were then 
boiled in a heat block for 6 min which was followed by cooling for 1 min on ice. The protein 
mixture was then centrifuged at the highest speed at 4⁰C for 2 min and used directly for 
loading on SDS-PAGE gels or stored at -20⁰C. 
2.6.2 Western Blotting 
 
Protein extracts were typically loaded on a 12% v/v SDS-PAGE gel which was run for 90 
min at room temperature. The prestained protein marker, broad range (7-175 kDa) from New 
England Biolabs (NEB) was used as a ladder in the gel. Proteins were then transferred to a 
nitrocellulose membrane (Protran BA-85, Geneflow) using a wet blotting apparatus 
(BioRad).  The transfer was carried out at 350 mA in transfer buffer (25 mM Tris, 192 mM 
glycine and 10% v/v methanol) at 4⁰C for 2 h. The membrane was then stained with Ponceau 
S to check that the proteins were transferred on the membrane uniformly. The membrane was 
blocked in Tris-buffered Saline containing 0.05% v/v Tween-20 (TBST) containing 5% w/v 
milk (Marvel) on a rocker for 1 h at room temperature. The membranes were incubated with 
primary antibody diluted in 1X TBST overnight at 4°C (dilution dependant on the 
concentration of the antibody). The membrane was washed five times with 1X TBST prior to 
secondary antibody incubation. The secondary antibody was HRP conjugated specific for the 
species and Ig class of the primary antibody (Chemicon), typically diluted 1:10000 in 1X 
TBST and incubated for 1 h on a rocker at room temperature. The membranes were washed 
again as before and incubated with Amersham ECL Prime Western Blotting Detection 
Reagent (GE Healthcare Life Science) for 5 min and then visualized with a GelVue Dual UV 




2.6.3 Reprobing of Western blot membranes 
 
Membranes were stripped using the Abcam stripping protocol. The membrane was washed 
with mild stripping buffer (15 g glycine, 1 g SDS and 10 ml Tween-20 in a 1L volume of 
water, pH 2.2) two times for 10 min each at room temperature. The membrane was then 
further washed with 1X PBS two times for 10 min followed by two times washed with 1X 
TBST for 5 min each at room temperature. The same membrane was blocked again with 
TBST containing 5% w/v milk and then re-probed with a different primary antibody as 
described above. As a loading control, membranes were typically incubated with a tubulin 
primary antibody (Sigma-Aldrich, T5168 1:4000) with the appropriate HRP conjugated 
secondary antibody.  
2.7 Fly genomic DNA extraction and Polymerase Chain Reaction 
 
A single male fly was first frozen at -20°C for 30 min in a PCR tube, then squashed against 
the tube wall using a pipette tip, in 50 µL ‘squishing’ buffer (10 mM Tris pH 8.0, 1 mM 
EDTA, 25 mM NaCl,). The sample was placed in a thermocycler for 30 min at 37°C 
followed by 2 min incubation at 95°C. It was then centrifuged and the supernatant was kept 
as genomic DNA and stored at 4°C.  
The PCR reaction was carried out in a 50 µL volume using Phusion® high-fidelity DNA 
polymerase (Biolabs) with the following parameters: 2 min at 98°C followed by 32 cycles of 





2.7.1 DNA Sequencing 
 
PCR products were purified using a QIAquick Gel Extraction Kit (QIAGEN) and were 
subsequently checked by running on a 1% w/v agarose gel.  The purified PCR product was 
then sent, with appropriate primers, to GATC Biotech (London) for sequencing (see 
Appendix V). 
2.8 Salivary gland dissection and polytene chromosome squashing 
2.8.1 Salivary gland dissection 
 
D. melanogaster larvae were grown at 18⁰C in bottles containing dry yeast. To obtain well-
squashed polytene chromosomes, larvae must be healthy. Salivary glands were dissected 
from wandering third instar larvae. Larvae were collected from the bottles and transferred 
into a dissecting glass dish filled with water which was placed on ice for 5 min for washing 
purposes and for the larvae to be put to sleep. Larvae were then dissected using sharp 
tweezers in 20 μl of solution A or the dissection buffer (100 μl 10x Buffer A, 100 μl 10% v/v 
Triton X-100, 800 μl distilled water; buffer A (1X): 15 mM HEPES pH 7.4, 60 mM KCl, 15 
mM NaCl, 1.5 mM spermine, 1.5 mM spermidine). For the fixation, salivary glands were 
kept for 1 min in 20 μl of solution B or the fixative (100 μl 10x Buffer A, 100 μl 10% v/v 
Triton X-100, 250μl 4% v/v formaldehyde, 550μl distilled water). Salivary glands were 
further washed for a few seconds in 20 μl of solution G (500 μl glacial Acetic acid, 250 μl 4% 
v/v formaldehyde and 250 μl distilled water) and then transferred to a siliconized glass 
coverslip containing 13 μl of solution G and incubated for a further 3 min. After that, the 
microscopic slide was gently put on top of the coverslip. It was also necessary to ensure that 
solution G was evenly spread between the slide and the coverslip.   
40 
 
 2.8.2 Squashing 
 
Salivary glands were first broken by tapping a few times on top of the coverslip with a blunt 
tip of a brush, dissecting needle or a similar implement. A piece of folded tissue paper was 
placed on top of the coverslip and then pressed using the thumb on a flat surface. The 
spreading of the chromosomes was checked under a phase contrast microscope. If 
satisfactory, the position of the coverslip was lightly marked with a diamond pencil on both 
sides of the coverslip and the slide was frozen by dipping into liquid nitrogen for 60 seconds. 
The coverslip was then quickly removed from the slide using a razor blade and put in a 
Coplin jar filled with 95% v/v EtOH and stored at -20°C. It could be used for 
immunostaining the following day. 
 
2.8.3 Immunostaining  
 
Slides with chromosome spreads were washed twice in a Coplin jar with 1X TBST (150 mM 
NaCl, 10 mM Tris-Cl pH 7.0-7.5, 0.05% v/v Tween). Each washing was performed at room 
temperature for 10 min. Slides were then transferred to a Coplin jar filled with blocking 
solution (TBS, 10% v/v Fetal Bovine Serum (FBS) and 0.05% w/v sodium azide (NaN3) and 
kept at room temperature for 30 min. Primary antibody was diluted in blocking solution 
(typically 1:100 dilution, depending on the antibody) and, as such, was used for 
immunostaining. A 20 μl drop of diluted antibody was placed on the coverslip and the slide 
with the chromosome was carefully placed on top of the drop, making sure that no air 
bubbles were formed between the slide and the coverslip. Slides were then placed in a humid 
chamber saturated with TBS and incubated overnight at 4⁰C.  
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Slides were removed from the chamber the following day and submerged into a beaker 
containing TBST in order to detach the coverslip from the slide without breaking the 
chromosomes. Slides were then washed twice with TBST at room temperature for 10 min.  
Secondary antibody staining was carried out in the same way as primary antibody but the 
dilution was typically 1: 250, as detailed in figures legend. The incubation with secondary 
antibody was performed in a humid chamber for 1 h at room temperature. In order to stain 
DNA, slides were first washed with TBST containing 0.1 μg/ml 4-6-diamidino-2-phenyl 
indol (DAPI, from Sigma-Aldrich) which was followed by a second wash in TBST for 10 
min. Slides were subsequently dried at room temperature for around 20 min, covered with 
aluminium foil to protect the secondary antibody-fluorophore from light. Once the slides 
were dried, they were mounted using a single drop of fluorescence Antifade medium 
(PromoFluor, Promokine) which was placed on a coverslip and carefully fitted on the slide 
allowing it to settle by capillary force.  Slides could be either viewed immediately using a 
fluorescence microscope or stored at 4⁰C for future use. 
2.8.4 Fluorouridine (FU) labelling of polytene chromosome nascent RNA 
 
Salivary glands were dissected in M3 media and incubated with 2mM 5-fluorouridine (FU, 
Sigma-Aldrich) at room temperature for 15 min. The cell membrane was then permeabilized 
by transferring the glands to solution A containing 1% v/v Triton X-100 and incubated at a 
room temperature for 2 min. Glands were subsequently transferred to solution A containing 
0.1% v/v Triton X-100 and incubated at room temperature for 10 min either with or without 
1µg/µl ribonuclease (RNAse, Invitrogen) treatment. All glands were then fixed in solution B 
for 1 min and squashed in solution G as described above. Immunostaining was carried out by 
following the protocol explained above.  
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2.8.5 Salivary gland RNase treatment 
  
Salivary glands were dissected in Solution A containing 1% v/v Triton X-100 and kept at 
room temperature for 2 min. Glands were then transferred to a 50 µl of solution A with 0.1% 
v/v Triton and incubated at room temperature for a further 10 min either with or without 1µg/ 
µl RNAse (Invitrogen). Glands were then fixed in solution B for 1 min and squashed in 
solution G. Immunostaining was carried out as described above.    
2.8.6 Acid-free polytene chromosome squashing  
 
To preserve the green fluorescent protein (GFP) signal, polytene chromosome squashing was 
carried out in 50% v/v glycerol instead of in acetic acid since the latter could destroy 
fluorescent signals. Salivary glands were routinely dissected in PBS and fixed in PBS 
containing 4% v/v formaldehyde (Agar Scientific) for 1 min. The glands were transferred to a 
50 µl of 50% v/v glycerol containing DAPI (0.1µg/ml) and incubated at room temperature for 
30 min. The salivary glands were squashed in a slide containing 20-30 μl of 50% v/v glycerol 
and  DAPI (0.1µg/ml) (Johansen et al., 2009). 
2.8.7 Salivary glands heat shock induction 
 
To induce heat shock protein genes on polytene chromosomes, larvae were placed in a 
standard fly food vial and immersed in a water bath at 37⁰C for 45 min to just below the rim 
of the vial. Larvae were dissected in solution A and processed following the standard 





2.8.8 Salivary glands ecdysone treatment protocol 
 
Incubation with 20-hydroxyecdysone (Sigma-Aldrich) was used to express ecdysone-
regulated genes in polytene chromosomes. Salivary glands were dissected in M3 media and 
incubated with 1µM ecdysone at room temperature for different time intervals (15 min, 30 
min, 1 h and 2 h). Salivary glands were then incubated for 1 min in solution A , followed by 
fixation for further 1 min  in solution B and both squashing, immunostaining was carried out 
using the explained protocol in section 2.8.1-2.8.3. 
2.8.9 Antibodies  
Antibodies against the EJC proteins - MAGO, Y14 and eIF4AIII - were all rabbit IgG 
generated by our collaborator Dr. Marco Blanchet (Stower Institute of Medical Research, 
USA). A 1:100 dilution was used per incubation. Primary antibodies against fluorouridine, 
Sm proteins and FLAG-tagged EJC proteins were mouse anti-BrdU (Sigma-Aldrich, 1:200 
dilution), mouse anti-Y12 (Thermo Fisher Scientific, 1:100 dilution) and anti-FLAG M2 
(Sigma-Aldrich, 1: 200 dilution) respectively. The secondary antibody used for the detection 
of the EJC primary antibodies was either Cyanine 3 (Cy3) conjugated goat anti-rabbit IgG 
(1:250 dilution), or fluorescein isothiocyanate (FITC) conjugated goat anti-rabbit IgG (1:200 
dilution). Secondary antibodies against Sm proteins, fluorouridine and FLAG tagged EJC 
proteins were detected by Alexa Fluor 647 conjugated goat anti-mouse IgG (Invitrogen, 
1:200 dilution). The primary antibody against RNA Pol II was mouse anti-Pol II H5 
(Covance, 1:250 dilution) which was subsequently detected by Cyanine 3 (Cy3) conjugated 
goat anti-mouse IgM (1:250 dilution). All the secondary antibodies were from Jackson 
Immuno Research Technologies and Life Technologies. 
44 
 
2.8.10 Fluorescence microscopy 
 
A Nikon Eclipse Ti epifluorescence microscope was used to view the stained polytene 
chromosomes using a 40X objective dry lens while the images were captured with an ORCA-
R2 camera (Hamamatsu Photonics).  
2.9 Whole salivary glands immunostaining 
 
Larvae were grown at 18°C in a glass bottle containing dry yeast to get well-fed larvae with 
big salivary glands. Larvae were dissected in M3 insect media and 4 to 5 pairs of glands were 
used for each experiment. All glands were fixed in a PBS solution containing 4% v/v 
formaldehyde (from 10% EM grade, Polyscience) and incubated on ice for 30 min. After 
fixation, salivary glands were washed with 0.3% v/v Triton in PBS three times for 10 min 
each at RT. All glands were then transferred to blocking solution (10% v/v FBS and 0.3% v/v 
Triton in 1X PBS) at room temperature for 1 h. After blocking glands were incubated with 
primary antibody (dilution depending on the antibody used) in a blocking solution overnight 
at 4°C. The following day glands were washed in PBS with 0.3% v/v Triton three times, 10 
min each, at room temperature. Glands were subsequently incubated with the appropriate 
secondary antibody (dilution depending on the antibody used) in blocking solution at room 
temperature for 2 h. Glands were washed again for 10 min in a PBS solution containing 0.3% 
v/v Triton, followed by staining with 0.1µg/ml of DAPI in the washing solution at room 
temperature for another 20 min. Glands were then incubated in the washing solution for 10 
min and then transferred to 50 µl of 50% v/v glycerol and incubated for 10 min at room 
temperature. All the glands were mounted in Antifade media (PromoFluor, Promokine) and 
viewed using a Leica SP2-AOBS confocal microscope. Images were further processed with 
ImageJ software (http://imagej.nih.gov/ij/). 
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2.10 Puromycin labelling of nascent peptides on polytene chromosomes 
2.10.1 Polytene chromosome squashing and ribo-puromycylation 
 
Optimization of puromycin labelling was carried out in two-steps. In the first step, salivary 
glands were dissected from 3rd instar larvae in M3 insect medium and kept in fresh media for 
up to 10 min.  Salivary glands were then incubated with 50 µg/ml puromycin and 100 µg/ml 
emetine in M3 media at room temperature for 15 min. After labelling, glands were washed 
three times for 5 min each in ice cold PBS with 100 µg/ml emetine. In the second 
optimization step, 10 µg/ml actinomycin D was added in both the labelling and the washing 
buffers. Salivary glands were then incubated in solution A with 100 µM aurintricarboxylic 
acid (ATA) and EDTA-free Complete Protease Inhibitor Cocktail (Roche) at room 
temperature for 2 min. Glands were then fixed for approximately 1 min in solution B and 
subsequently squashed in solution G. Slides were stored at 4°C in 95% v/v ethanol. 
2.10.2 Immunostaining and antibody 
 
Before immunostaining, slides were washed twice in TBS (150 mM NaCl, 10 mM Tris-Cl pH 
7.0-7.5, 0.05% v/v Tween) for 10 min. Slides were incubated in a TBS blocking solution 
containing 10% v/v Fetal Bovine Serum (FBS) and 0.05% w/v sodium azide (NaN3) at room 
temperature for 30-60 min. All chromosome spreads were stained with 0.1 µg/ml DAPI for 
20 min. The antibody used was an Alexa 488-conjugated 2A4 monoclonal antibody (from Dr. 
John Yewdell, NIH, USA) (David et al., 2012) and was diluted 1:200 in blocking buffer. The 
slides were mounted with a drop of fluorescence Antifade medium (PromoFluor, Promokine). 
Stained polytene chromosomes were viewed using an epifluorescence Nikon microscope with 
a 40X objective lens and images were captured using a CCD camera. 
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2.11 Incorporation of puromycin  in whole salivary glands of D. melanogaster 
2.11.1 Puromycin and emetine labelling 
  
Salivary glands from 3rd instar larvae were dissected in M3 media. Glands were incubated in 
M3 media either containing both 50 μg/mL puromycin and 100 μg/mL emetine or 50 μg/mL 
puromycin only. The incubation was at room temperature for 15 min and followed by three 5 
min washes in ice cold PBS containing 100 μg/mL emetine. This was followed by a 1 min 
incubation of a pair of glands in emetine (100 μg/mL), 60 mM KCl, 15 mM NaCl, 15 mM 
HEPES pH 7.4, 1.5 mM spermine, 1.5 mM spermidine, 100 μM aurintricarboxylic acids 
(ATA), 1% v/v Triton X-100, and EDTA-free Complete Protease Inhibitor Cocktail (Roche) 
at room temperature.  
As a control, glands were pre-incubated with 2µM harringtonine in M3 media at room 
temperature for 15 min, before the previously explained puromycin/emetine treatment. All 
subsequent steps were carried out as above.  
2.11.2 Immunostaining 
 
After labelling, salivary glands were fixed in a PBS solution containing 4% v/v formaldehyde 
for 30 min on ice. Glands were then washed twice in PBS containing 0.3% v/v Triton X-100 
for 10 min each at room temperature. Salivary glands were then incubated with 10% v/v FBS 
in PBS and 0.3% v/v Triton X-100 for 1 h at room temperature which was followed by 
incubation with the Alexa 488 conjugated 2A4 monoclonal antibody (1:200 dilution) at 4°C 
overnight. Glands were subsequently washed in PBS containing 0.3% v/v Triton X-100 and 
0.1 µg/ml DAPI at room temperature for 20 min. A further wash without DAPI was carried 
out at room temperature for another 10 min and glands were mounted on the slide with anti-
fade media. Sample was either viewed immediately or stored at 4°C.  
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2.11.3 Confocal microscopy/image processing 
 
A Leica confocal inverted microscope (DMIRE2) with a 40X and 63X oil objective lenses 
was used to view glands and images were captured using Leica Confocal Software Suite.  
2.12 Genetics 
 
D. melanogaster was used in all of the above experiments.  Fly stocks were kept in standard 
fly food plastic or glass vials with dry yeast. Fly stocks were maintained either at 18°C or 
25°C depending on the required experimental purpose. Fly stocks kept at 18°C were normally 
transferred to fresh vials after 28 days, while those at 25°C stock were transferred every 14 
days. 
2.12.1 Virgin collection 
 
To collect virgin female flies, fly vials were emptied in the evening and kept at 18°C. Virgin 
female flies were collected the following morning, vials were kept at 25°C and virgins were 
collected as they emerged throughout the day. Virgin females were identified by the presence 
of meconium in the gut. The lower temperature (18°C) delays the emergence of flies. Virgin 
females were kept at 18°C until required. 
2.12.2 Setting up crosses 
 
To set up a cross, four virgin females were typically crossed with two males in glass vials with 
freshly sprinkled dry yeast. The vials were kept at 25°C for two days and then transferred to 
fresh fly foods vials. To get well-fed larvae with big salivary glands, vials were kept at 18°C. 
Third instar larvae could then be dissected on the 10th day after egg laying. 
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2.12.3 GAL4/UAS expression system 
 
The GAL4/UAS system is one of the most well-known systems used in Drosophila which 
provides tissue-specific transgene expression. The yeast transcription activator, Gal4, binds to 
yeast upstream activating sequences (UAS) and induces transcription of corresponding genes 
(Duffy, 2002). Gal4 serves as a driver in this system and acts on any gene flanked by the 
UAS sequence. To express UAS-regulated transgenes in specific tissue/cells, the UAS line 
was crossed with a specific Gal4 driver line. 
2.12.4 Generation of a fly strain expressing both LacI-GFP and MCP-RFP  
 
To produce LacI-GFP and MCP-RFP on the same transgenic flies, a genetic cross was set up 
as following: flies strain with MCP-RFP y[1] w[67c23]; P{w[+mC]=Hsp83-MCP-
RFP}12a/TM3, Sb[1] on the 3rd chromosome and strain with lacI-GFP 6(4:1)/ Cyo 
hsp83.GFP-Lac I on the 2nd chromosome were crossed using standard genetics protocols 
(Figure 2.2). In the G0 cross, a homozygous red eyed male with [Cyo-Hsp83. GFP-Lac I] 
(see Appendix III) on the 2nd chromosome (cross a) and P W[+mc]= Hsp83-Mcp RFP (see 
Appendix III) on the 3rd chromosome (cross b) were crossed with double balancer virgin 
females. Red eye males from the F1 (a) progeny, with IF and TM6B markers, were crossed 
with red-eye virgin females with Cyo and MKRS of the F1(b) progeny. Then F2 flies with 
the indicated genotypes were crossed to produce F3 flies homozygous for both inserts, which 
were selected for the absence of both Cyo and TM6B dominant markers. The strain was 
initially verified by observing the larvae on fluorescence microscope and by inspecting the 







Figure 2.2 Schematic representation of genetic cross of LacI - GFP and MCP-RFP - In 
the G0 (a) and G0 (b) phase LacI-GFP and MCP-RFP cross with double balancer lines. F1 (a) 
and F1 (b) generation were collected by observing the above phenotype and were further 




2.13 Parameters used to select target epitopes for UPF1 and UPF2 
 
Abmart SEAL technology was used to produce the monoclonal antibody against UPF1 and 
UPF2 protein (Figure 2.3). The protein amino acid sequence for UPF1 and UPF2 were given 
in Table 2.1 and 2.2.  Abmart Bioinformatics tools and algorithm antigen software were used 
to design the protein secondary structure and potential epitopes. Following is the most 
important parameter considered in algorithm to design the epitopes 
1.   Secondary structure-Loop/helix/sheet 
2. Special region- N-terminal, C-terminal, signal peptide, Trans-membrane, Solvent 
accessibility. 
3.    Blast- Query species and Mouse 
4.    Amino Acid property- Antigenic enhancement amino acid Flexibility 
5.    Evolution- Positive selection, Discrimination 





Figure 2.3 Abmart SEAL technology for antibody production 
Abmart designs potential epitopes by using specific algorithm antigen software. The potential 
epitopes then integrated into the Abmart expression vector to produce recombinant antigen, 











































Table 2.1 & 2.2 Represents the amino acid sequence of UPF1 and UPF2 used to produce 






2.13.1 Step wise Antibody production from Abmart 
 
The selected Protein immunogen was over-expressed in E. coli, and Ni-affinity 
chromatography was used to further purify the immunogen. Purified immunogen were then 
immunized to three 8 to 12-week old laboratories- bred strain of house mouse (BALB/C 
mice, female). After immunization, the mouse that shows the desired immune-response were 
selected for hybridoma production. To produce the hybridoma, SP2/0 myeloma cells fused 
with selected mouse spleen cells. Next both cell mixtures were diluted, and hypoxanthine-
aminopterin-thymidine (HAT) were used to grow the clone from single parent cells on 
microtitre wells. Secreted antibodies were then assayed by enzyme - linked immunosorbent 
assay (ELISA) based on their binding affinity towards antigen from different clones. Once 
the desired clone selected, the hybridoma cells were injected into the peritoneal cavity of 
mice. These produced tumors in mice after 10-14 days of injection and these tumors filled 
with an antibody-rich fluid called ascites fluid. These ascites fluids were then used for 
screening the best antibody. Once the desired clone was chosen, the Protein A/G affinity 
chromatography used to purify further the antibody. 
2.14 Statistical analysis 
 
Analysis of variance (ANOVA) one-way test was used to check the mean values among the 
RNAi treatment groups with the control group. Statistical significance calculated with Power 
of performed test with alpha = 0.050: 1.000. P< 0.05 indicates difference is statistically 
significant, whereas, P>0.05 denotes the difference is due to random sampling variability; 




                                                          Chapter 3 
 
3.0 EJC components associate with transcription sites on Drosophila polytene 
chromosomes 
3.1 Summary or Introduction 
 
The Exon Junction Complex (EJC) is a multi-protein complex that binds to the mRNA after 
splicing in the nucleus, and is one of the best characterised components of messenger 
ribonucleoprotein particles (mRNPs). Binding of the EJC assists with the passage of an 
mRNA through the nuclear pore to the cytoplasm, where it determines the fate of mosts 
mRNAs.  To date, most evidence stipulates that this complex has a significant role in 
downstream events.  EJC has a crucial role in NMD, where it contributes to recognition and 
degradation of mRNAs containing premature translation termination codons (PTCs) in the 
cytoplasm of mammalian cells. In addition, this complex also has a prime role in enhancing 
translation and localization of the mRNA (Mohr et al., 2001; Nott et al., 2004). However, 
more recent studies show that this complex is required for the splicing of genes that contain 
long introns, and loss of this complex results in abnormally spliced transcripts (Ashton-
Beaucage et al., 2010; Ruiz-Echevarria et al., 1998). Since splicing is typically a co-
transcriptional event, I aimed to visualize the recruitment of EJC proteins at transcription 
sites on Drosophila melanogaster polytene chromosomes, providing a unique system to 
visualize transcription, pre-mRNA processing and associated factors. I used indirect 
immunostaining to localize three proteins that constitute the core of the EJC. Here I report 
that association of these proteins with gene loci is transcription dependent, but surprisingly, 
RNA independent. Notably, their association with both intron-containing and intron-less 
genes, arguing against current predictions that the EJC binds only spliced mRNAs or intron 
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containing pre-mRNAs. To further characterise the role of EJC proteins at transcription sites, 
I carried out chromatin immunoprecipitation, followed by high-throughput sequencing (ChIP-
seq), of the EJC proteins and found that the core EJC component Y14 accumulates at 
transcription start sites. I also showed experimental evidence that Y14 and MAGO might be 




3.2.1 The core EJC proteins are abundant in both nucleus and cytoplasm 
 
 The core EJC proteins, Y14, MAGO, and eIF4AIII, are present in both the nucleus and 
cytoplasm of cells across organisms and cell types. This feature is apparent in salivary glands, 
which are composed of large cells with polytenic nuclei, providing a good cell model to 
visualize the subcellular localization of the proteins (Hochstrasser and Sedat, 1987). 
Immunostaining of whole salivary glands show that all three EJC proteins are present in both 
the nucleus and cytoplasm (Figure 3.1 A). While the signal appears more intense in the 
nucleus, particularly around the chromosomes, a strong signal is visible in the cytoplasm, 
although not in the vesicles, which are abundant at this stage of larval development, prior to 
the peak of secretion of glue protein (Biyasheva et al., 2001). Moreover, knockdown of Y14 
and MAGO in salivary glands significantly reduced the signal compared to control glands 
(Figure 3.1 B). The knockdown experiment was carried out by crossing fkh-Gal4 lines with 
Y14 RNAi and MAGO RNAi lines, described later in this chapter. These findings suggest 
that antibodies are specific against the Drosophila endogenous Y14 and MAGO. In addition, 
specificity of these antibodies was also checked in S2 cell extracts by Western blotting. From 
the western blot, all antibodies show a single band corresponding to endogenous proteins, 
with minimal cross-reactivity (Figure 3.1 C). These antibodies were raised in rabbit and 
affinity purified by our collaborator Dr. Marco Blanchette (Stowers Institute for Medical 
Research, USA). To provide a more quantitative estimate of the levels of EJC proteins in the 
nucleus compared to cytoplasm, I assayed the three proteins by Western blotting of nuclear 
and cytoplasmic fractions of Drosophila S2 cells.  I found these proteins to be equally 
distributed between the two compartments (Figure 3.1 D). As the volume of the cytoplasm is 








Figure 3.1 Subcellular localization of EJC proteins in salivary glands 
(A) Indirect immunostaining of whole salivary glands with anti-Y14, anti-MAGO and anti-
eIF4AIII antibodies, and detected with Cy3 conjugated (red signal) secondary antibody, 
showed a signal in both the nucleus and cytoplasm. Glands were counterstained with DAPI 
(middle panels), and rightmost panels show the merged channels of Cy3 and DAPI. (B) Y14 
RNAi (S-305, ID-36585, see Appendix III) and MAGO RNAi (S-252,ID-28132, see 
Appendix III) lines were crossed with fkh-Gal4, to express dsRNA against the endogenous 
Y14 and MAGO in salivary glands, and stained with anti-Y14 and  anti-MAGO antibodies. 
(C) Western blot of whole S2 cell extract, immunoblotted with Y14 (lane 3, 19.01 kDa), 
MAGO (lane 2, 17.31 kDa) and eIF4AIII (lane 1, 45.65 kDa). (*) denotes might be the 
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degradation product of eIF4AIII in lane 1 and isoform of Y14 at lane 3.  (D) Distribution of 
Y14, MAGO and eIF4AIII in the nuclear fraction (lane 1) cytoplasmic fraction (lane 2) of S2 
cells and of whole cell lysate (lane 3), detected with anti-Y14, anti-MAGO and anti-eIF4AIII 
via Western blot. 
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3.2.2 Visualization of EJC components at polytene chromosome transcription sites  
 
The polytene chromosomes of Drosophila melanogaster are expanded interphase 
chromosomes, each locus containing around a thousand copies of each gene, therefore 
providing an effective system to analyse the association of individual proteins with sites of 
transcription and nascent pre-mRNA (Hochstrasser and Sedat, 1987; Matunis et al., 1993). 
Pre-mRNA splicing is typically co-transcriptional in Drosophila (Khodor et al., 2012); so I 
used the polytene chromosomes to gain insights into why the EJC seems to associate only 
with a subset of transcripts in Drosophila (Sauliere et al., 2010). I performed indirect 
immunostaining with antibodies for the three EJC core proteins, Y14, MAGO, and eIF4AII. 
All three antibodies predominantly stain the interbands of the polytene chromosome, which 
are decondensed segments containing one or more actively transcribed gene loci (Figure 3.2 
A). The signals from all three EJC proteins colocalize with that of hyperphosphorylated RNA 
polymerase II (Pol II
Ser2
) (Figure 3.2 B), which is a marker of active transcription elongation 
(O'Brien et al., 1994). As expected from the observation that Y14 and MAGO form a stable 
heterodimer in vitro (Lau et al., 2003), the staining patterns of Y14 and MAGO are very 
similar; this is most apparent at the cytological regions 58E, 56E, 50C and 53D which can be 
mapped using the DAPI banding pattern (further evidence that Y14 and MAGO colocalize 
will be show further below). However, as exemplified by position 60E, other sites show 
intense eIF4AIII signals yet Y14 and MAGO signals are either absent or very faint (Figure 
3.2 A). This difference in staining pattern is more apparent by comparison to parallel Pol 
II
Ser2 
immunostaining; eIF4AIII is observed at every Pol II transcription site, but the Y14 and 
MAGO signals are either absent or weak at intense Pol II
Ser2 
sites (Figure 3.2 B, indicated by 
arrows). In contrast, at some other sites I detected relatively strong EJC protein signals but 
weak Pol II
Ser2











Figure 3.2   EJC core components are at transcription sites of polytene chromosomes 
 (A) Indirect immunostaining of chromosome squashes with anti-eIF4AIII (top panel), anti-
Y14 (middle panel) and anti-MAGO (bottom panel) primary antibodies, subsequently 
detected using a Cy3-conjugated (red signal) secondary antibody. The yellow arrows indicate 
the positions of the most apparent interbands in all channels, while the white line shows the 
position of a highly intense eIF4AIII signal that is faint in Y14 and MAGO staining. The 
middle panels show DAPI (blue) to mark DNA, whereas the top right channels are the 
merged images of DAPI and Cy3.  
(B) Double immunostaining was performed with antibodies against each of the three EJC 
components and against hyperphosphorylated RNA Pol II
Ser2
 (H5). EJC proteins were 
detected with a FITC-conjugated secondary antibody (green) while Pol II was detected with a 
Cy3-conjugated secondary antibody (red signal).  White arrows indicate the position of a 
strong Pol II
Ser2
 signal but weak EJC signals, whereas the yellow line shows a strong EJC but 
weak Pol II signal. All images were counterstained with DAPI to show the DNA. Images 




3.2.3 Colocalization confirms Y14 and MAGO might form a heterodimer at same 
transcription sites  
 
As shown above, immunostaining of polytene chromosomes gives similar banding patterns 
for both Y14 and MAGO, consistent with the proteins forming a stable heterodimer. To 
directly investigate the extent of Y14 and MAGO colocalization at the chromosomes, and in 
general to characterise more in detail the association of EJC proteins with transcription sites, 
I made use of transgenic fly lines encoding Y14 and eIF4AIII, double tagged at their C-
termini with 2x FLAG and 2x HA epitopes (these strains were generated by our collaborator 
Dr Marco Blanchette). The transgenes  are under the control the UAS promoter, so can be 
expressed in salivary glands by crossing them with the forkhead-Gal4 driver, which is highly 
expressed salivary glands (Henderson and Andrew, 2000). Western blotting of salivary gland 
extracts shows that the double-tagged Y14 and eIF4AIII proteins migrate as predominantly a 
single band of the expected size (Figure 3.3 A & B). These tagged proteins appear to be 
functional, since immunostaining revealed a chromosomal banding pattern very similar to 
that of endogenous Y14 and eIF4AIII (Figure 3.3 C). Specifically, both FLAG-tagged Y14 
and endogenous Y14 give the same pattern on chromosomal sites when I carried out double 
immunostaining with antibodies against the FlAG-tagged Y14 and endogenous Y14 (Figure 
3.4 A). The same approach was also used for FlAG-tagged eIF4AIII and endogenous 
eIF4AIII (Figure 3.4 B). Next, to directly assess the extent of co-localization of Y14 and 
MAGO, I crossed the FLAG-tagged transgenic lines with the forkhead-Gal4 driver, dissected 
salivary glands from mid-3
rd
 instar larvae and stained the polytene chromosome with anti-
FLAG and anti- MAGO to detect tagged-Y14, and endogenous MAGO. The immunostaining 
signals of the two proteins show complete colocalization along the chromosomes and in the 
nucleolus (Figure 3.5). Chromosomes were also stained with DAPI and the co-localization 
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signal was comparable in the merged channel at transcribed gene loci.  The above results 
strongly indicate that Y14 and MAGO might form a constitutive heterodimer at transcription 










Figure 3.3 FLAG-tagged EJC protein shows identical signal patterns throughout the 
polytene chromosome. (A) & (B) Western blot of salivary glands from eIF4AIII FLAG/HA-
tagged (S-259, see Appendix III) and Y14 FLAG/HA-tagged (S-253, see Appendix III) 
transgenic lines and immunoblotted with anti-FLAG M2 and anti-HA antibodies. Lane 1(A): 
HA-tagged eIF4AIII (50.15 kDa), lane 2: FLAG-tagged eIF4AIII (50.15 kDa) and lane 3 
used as a negative control.  Lane 1(B): FLAG-tagged Y14 (24 kDa), lane 3: HA-tagged Y14 
(24 kDa) and lane 2 and 4 used as a negative control. (C) FLAG/HA-tagged Y14 and 
FLAG/HA-tagged eIF4AIII transgenic lines were crossed with an fkh-Gal4 driver (see 
Appendix III) and immunostained with an anti-FLAG M2 antibody (leftmost panels). A Cy3-
conjugated (red signal) secondary antibody was used to detect FLAG-Y14 (top panel) and 
FLAG-eIF4AIII (bottom panel). The middle panels show DAPI (blue) staining to mark DNA, 
whereas the right channels are the merged images of DAPI and Cy3. The images were taken 









Figure 3.4 Expressed EJC proteins colocalize with endogenous EJC in the polytene 
chromosome. (A) & (B) Colocalization of FLAG-tagged Y14 (S-253, see Appendix III) with 
endogenous Y14 and FLAG-tagged eIF4AIII) ( S-259, see Appendix III) with endogenous 
eIF4AIII. Expressed FLAG-tagged proteins were detected with an anti-FLAG M2 antibody 
(top-left panels in A&B) and endogenous Y14 and eIF4AIII were detected with anti-Y14 and 
anti-eIF4AIII (top-right panels in A&B). Subsequently, an Alexa Fluor 647-conjugated 
secondary antibody (red signal) and FITC-conjugated secondary antibody (green) were used 
against FLAG and endogenous Y14 and eIF4AIII.  Arrows indicate the nucleolus. DAPI 
(blue) was used to stain the DNA (bottom-left panels in A&B), and rightmost panels are a 
merged image of blue, red and green channels. Images were captured with an epifluorescence 





Figure 3.5 Y14 and MAGO localize at same transcription sites. 
  
 Double immunostaining with an anti-FLAG antibody to detect expressed FLAG-tagged Y14 
(top-left) (S-253, see Appendix III) and anti-MAGO to detect endogenous MAGO (top-
right). Subsequently, an Alexa Fluor 647 conjugated secondary antibody and a FITC-
conjugated secondary antibody were used to detect FLAG-tagged Y14 (in red) and 
endogenous MAGO (green). The yellow arrows indicate MAGO and FLAG-tagged Y14 
signals in the nucleolus. The chromosome was also stained with DAPI (bottom-left panel); 
the colocalization signals more apparent in the merged channels (bottom-right). Images were 




3.2.4 Association of Y14 and MAGO with transcription sites differs from that of 
eIF4AIII 
 
 The EJC component eIF4AIII is thought to be the nucleating component of the complex. The 
protein is the first to be recruited at a splice junction by its direct interaction with the 
spliceosomal protein CWC22. Current models envisage that Y14 and MAGO bind eIF4AIII 
at the exon junction upon the latter dissociating from CWC22 (Barbosa et al., 2012; 
Steckelberg et al., 2012). The banding pattern of eIF4AIII at polytene chromosomes is 
different from that of Y14-MAGO. As shown above (Figure 3.2 B), the most apparent 
difference is that while eIF4AIII is at essentially every Pol II transcription site, there are 
many sites at which Y14 and MAGO signals are either absent or very faint, compared to both 
eIF4AIII and Pol II. To investigate this unexpected observation further, I performed a double 
immunostaining for endogenous Y14 and FLAG-tagged eIF4AIII using the transgenic line 
described above. These experiments clearly demonstrate that Y14 (and by inference, MAGO) 
are absent from sites in which a very strong eIF4AIII signal is detected (Figure 3.6). These 
results suggest that the association of Y14/MAGO at transcription sites is not directly linked 
to that eIF4AIII. The results indicate that the EJC may not be recruited at many active 






Figure 3.6 Association of eIF4AIII poorly correlates with Y14   
 
Double immunostaining with an antibody against FLAG to detect expressed FLAG-tagged 
eIF4AIII (top-left) (S-259, see Appendix III) and anti-Y14 to detect endogenous Y14 (top-
right) in polytene chromosomes. An Alexa Fluor 647-conjugated secondary antibody was 
used to detect FLAG-tagged eIF4AIII (in red) and a FITC-conjugated secondary antibody 
(green) was used against endogenous Y14. The white arrow indicates the nucleolus.  Yellow 
arrows highlight locations where there is a positive FLAG-tagged eIF4AIII but where the 
Y14 signal absent. Chromosomes were also stained with DAPI (bottom-left panel), and the 
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bottom-right panel is a merged image of the DAPI, red and green channels. Images were 






3.2.5 Knockdown of the core EJC component eIF4AIII affects the development of 
Drosophila salivary glands in vivo 
  
 In order to study the mechanism of EJC recruitment at transcription sites, I used an in vivo 
approach to knockdown each EJC components (Y14, MAGO and eIF4AIII) in salivary 
glands. To knockdown these proteins we obtained Y14 and eIF4AIII RNAi lines from 
Bloomington (see Appendix III) and a MAGO RNAi (see Appendix III) from Vienna.  These 
RNAi lines were all under the control of the GAL4/UAS system, therefore, a forkhead-Gal4 
driver was used to express dsRNA against the target protein in salivary glands. The RNAi 
lines were crossed with forkhead-Gal4 lines and salivary glands were dissected from mid-3rd 
instar larvae. Knockdown of Y14 and MAGO does not have any obvious phenotypic effect in 
salivary glands compared to control condition (Figure 3.7 A). However, knockdown of 
eIF4AIII makes the glands significantly smaller in size compared to the Y14 and MAGO 
knockdowns. Additionally, in a parallel study, in which the nucampholin (ncm) gene was 
knocked down, a similar phenotype was observed in salivary glands (Figure 3.7 A). 
Drosophila NCM is a homologue of human pre-mRNA splicing factor CWC22, which 
interacts with eIF4AIII during early stages of splicing (Alexandrov et al., 2012; Barbosa et 
al., 2012). Although it is not yet clear whether CWC22 and eIF4AIII are recruited as a 
heterodimer during splicing, the observation that knockdown of both ncm and eIF4AIII give 
a similar phenotype suggests that eIF4AIII possibly has a role in splicing in conjugation with 
CWC22. Additionally, these studies also indicate that eIF4AIII has an independent role in 
salivary gland development and functions beyond the EJC complex. A similar observation 
was reported in mice, where knockdown of MAGO reduced both body and brain size by 
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regulating neural stem cell division (Silver et al., 2010). These findings demonstrate that the 
EJC core components function independently, besides have a role in post transcriptional 
events of mRNA.  The knockdown efficiency of both Y14 and MAGO were confirmed in 
salivary glands by Western blot (Figure 3.7 B) and was found to be comparable to that in S2 









Figure 3.7 eIF4AIII is required for salivary gland development in Drosophila  
 
(A) Y14, MAGO, eIF4AIII and NCM were selectively knocked down in salivary glands 
using RNAi lines. RNAi lines received from Bloomington include Y14 RNAi (ID-36585, S-
305) and eIF4AIII RNAi (ID-32444, S-307) while MAGO RNAi (ID-28132, S-252) and 
NCM RNAi (S-314, ID-17304) (See Appendix III for all RNAi lines) lines were from 
Vienna. Each of these RNAi lines was expressed in salivary glands by crossing with the fkh-
Gal4 driver. Knockdown of eIF4AIII and NCM makes the gland significantly small (bottom 
right panel VIII &X)) compared to the control wild-type (top right), Y14 RNAi and MAGO 
RNAi. Yellow arrows show salivary gland size, while the white arrow indicates the fat body 
upon knockdown of NCM (bottom right panel, X). However, there were no such changes 
observed in 3
rd
 instar larvae size (left panels). (B) Western blot analysis to check the 
knockdown efficiency of Y14 and MAGO in the salivary gland. Lanes 1 and 2 show 
immunoblotting with Y14 and lanes 3 and 4 show immunoblotting with MAGO. Knockdown 






3.2.6 Y14 is required for the association of MAGO with transcription sites in vivo 
 
While eIF4AIII knockdown makes glands too small for preparing chromosome squashes, 
neither RNAi of Y14 nor MAGO hinders larval development or polytenization, therefore it 
was possible to directly assess whether knockdown of Y14 affects recruitment of MAGO at 
transcription sites, and whether either of them is involved in eIF4AIII chromosomal 
association. To address this issue, I first analysed Y14 RNAi lines crossed with forkhead-
Gal4 lines and salivary glands dissected from mid-3
rd
 instar larvae. Staining with a Y14 
antibody shows drastically reduced the Y14 signal from the chromosomal sites, (Figure 3.8 
A). The MAGO signal however, was completely gone from both chromosomes and the 
nucleolus. Notably, knockdown of Y14 has no effect on the association of eIF4AIII with 
transcription sites, as signals are still present at transcriptional loci (Figure 3.8 A). The results 
from these data suggest that Y14 is required for the recruitment of MAGO at actively 
transcribed gene loci, but that Y14 is not required for eIF4AIII chromosomal association. 
Secondly, I analysed the effect of MAGO knockdown of the association of Y14. Consistent 
with Western blotting results (Figure 3.7B), the MAGO signal is drastically reduced (Figure 
3.8 B); however, that of Y14 was only partially reduced at the chromosomes, and was very 
intense in the nucleolus (Figure 3.8 B). MAGO is therefore not necessary for Y14 association 
with transcription sites. The partial reduction in the Y14 signal might be the result of 
destabilization of the protein rather than MAGO being required for recruitment and 
association with the chromosomes. As observed earlier for Y14, MAGO knockdown does not 







Figure 3.8 Y14 recruitment does not require MAGO but MAGO recruitment does 
require Y14  
(A) Y14 RNAi lines from Bloomington (ID-36585, S-305), were crossed with an fkh-Gal4 
driver to knockdown Y14 in salivary glands which were subsequently immunostained with 
Y14 (top-left) MAGO (middle-left) and eIF4AIII (bottom-left). A Cy3-conjugated (red 
signal) secondary antibody was used to detect EJC proteins. An arrow (in yellow) indicates a 
strong Y14 signal in the nucleolus (top-left panel). Y14 knockdown eliminates the MAGO 
signal from transcription sites, whereas there was no effect on the eIF4AIII signal. All images 
were also stained with DAPI, and the rightmost panels are the merged images of DAPI and 
Cy3 signals. (B) In a similar way, MAGO RNAi lines from Vienna (ID-28132, S-252) were 
used to knockdown MAGO in salivary glands which were subsequently stained with MAGO 
(top-left), Y14 (middle-left) and eIF4AIII (bottom-left).  These proteins were again detected 
with Cy3-conjugated (red signal) secondary antibody. MAGO knockdown partially 
eliminates the Y14 signal, and this was more apparent in the magnified inserts of the main 
image (indicated by the box) in the merged channels. All slides were counterstained with 
DAPI and merged images are shown in the rightmost panels. The images were taken under a 





3.2.7 Dimerization stabilizes Y14 and MAGO 
 
The results shown above, as well as published data, suggest that Y14 and MAGO form a 
heterodimer, but why this heterodimer is important for these two proteins is poorly 
understood. To further investigate the role of Y14 and MAGO heterodimerization, I 
selectively knocked down the core EJC components Y14, MAGO and eIF4AIII, in 
Drosophila S2 cells. Knockdown efficiency was verified by both Western blotting and q-RT-
PCR. A significant level of knockdown was achieved for Y14, and was almost complete for 
MAGO. However, the knockdown level of eIF4AIII was less compared to Y14 and MAGO 
(Figure 3.9 A). Notably, Y14 knockdown also drastically reduces MAGO expression, as 
determined by the observation that the MAGO signal was completely gone when carrying out 
Western blotting (Figure 3.9 B). In the same way I investigated the effect of knocking down 
MAGO and then blotting for Y14, however, the signal for Y14 although reduced, was not 
depleted completely (Figure 3.9 C).  In both cases, eIF4AIII was affected to a lesser extent 
compared to Y14 and MAGO. This raises the possibility that Y14 might affect MAGO 
transcript levels. To evaluate this possibility, I checked the transcript levels of both Y14 and 
MAGO knockdowns in S2 cells. The result was that knockdown of Y14 does not affect 
transcript levels of MAGO and neither does knockdown of MAGO affect those of Y14 
(Figure 3.9 D & E).  These results therefore suggest that Y14 and MAGO heterodimerization 











Figure 3.9 Y14 and MAGO dimerization is required for the stability of this complex 
A) Y14, MAGO and eIF4AIII were selectively knocked down in S2 cells by expressing 
dsRNA against the endogenous proteins. Knockdown efficiency was checked by Western 
blot with antibodies against eIF4AIII (lanes 1 and 2), MAGO (lanes 3 and 4) and Y14 (lanes 
5 and 6). (B) Western blot to check the protein levels of MAGO upon knockdown of 
eIF4AIII (lane 1), Y14 (lane 2) and in control S2 cells (lane 3). (C)  Western blot to check the 
protein levels of Y14 upon knockdown of eIF4AIII (lane 1), MAGO (lane 2) and in control 
S2 cells (lane 3). Tubulin was used as a reference control in all of the above experiments. (D) 
& (E) qRT-PCR to check transcript levels of Y14 and MAGO in S2 cells upon knockdown of 
Y14 and MAGO. The fold enrichment method was used for calculation and normalized to 





3.2.8 Association of EJC core components at transcription sites seems RNA independent 
 
As described above, all three EJC core proteins (Y14, MAGO and eIF4AIII) are present at 
transcription sites. Current observations predict that the association is primarily with nascent 
RNA. To test the prediction, I treated the polytene chromosome with RNase A (see details in 
Material and Methods and figure legends). As a positive control I made use of Sm proteins, 
which are core shared components of the small nuclear ribonucleoproteins (snRNPs) that 
form the spliceosome (Will and Luhrmann, 2001). An antibody specific for Sm proteins 
stains polytene chromosome transcription sites and the signal is characteristically highly 
sensitive to RNase A treatment (Matunis et al., 1993). As predicted by the observations 
described above (Figure 3.2A.), I found that Y14 is present at many but not all transcription 
sites, some of which are Sm-positive while others are not (Figure 3.10 A). Notably, while 
RNase treatment completely removed the Sm signal in all chromosome squashes treated, that 
of Y14 was reproducibly indistinguishable from that in control squashes (Figure 3.10 B). 
These data suggest that the association of Y14 with transcription sites might not be via RNA. 
The same result was also observed with the other core protein, eIF4AIII (Figure 3.10 C-D). 
Although RNase sensitivity was not tested for MAGO, since is constitutively paired with 













Figure 3.10 Association of EJC proteins is RNA-independent (A) Top panel indicates  
double immunostaining with anti-Y14 and anti-Y12 (Sm) and (C) anti-eIF4AIII and anti-Y12 
in the polytene chromosome shows the Y14, eIF4AIII and Sm signals to be present at most 
transcription sites in the absence of RNase. Subsequently, anti-Y14, anti-eIF4AIII and anti-
Y12 were detected with a FITC-conjugated secondary antibody (green) and an Alexa Fluor 
647-conjugated secondary antibody (red signal).  Arrows indicate sites where the Sm signal 
did not colocalize with Y14 and eIF4AIII.  Bottom (B) and (D) panel shows that following 
treatment with 1 µg/µl RNase A, the Y14, and eIF4AIII signals persist, whereas the Sm 
signal is absent from transcription sites. All samples were also counter stained with DAPI 
(blue) and the rightmost bottom panels show the merged images of DAPI, red and green 
channels. Images were taken using a standard epifluorescence microscope with a 40X 




3.2.9 Nascent RNA labelling indicates EJC core proteins are not primarily associated 
with pre-mRNA 
 
Having observed that Y14 and eIF4AIII resist RNase treatment, it is possible that the 
recruitment of core EJC proteins at transcription sites is independent of RNA. While the 
snRNAs to which Sm proteins are bound could be more sensitive to RNase than nascent 
RNA, these observations suggest that the protein components of nascent RNA, such as the 
EJC, can make RNA-independent secondary contacts with chromatin or DNA directly. To 
address this issue, I labelled nascent RNA with fluorouridine. The function of fluorouridine is 
comparable to bromouridine as both are uridine derivatives used to label nascent RNA 
(Chang et al., 2000). To label the nascent RNA in this way, polytene chromosomes were first 
incubated with fluorouridine for 15 minutes prior to RNase A treatment, and a parallel 
control sample was prepared without RNase treatment (see details in Material and Methods). 
As expected, signals for both Y14 and fluorouridine are seen at many interbands in the 
control (Figure 3.11 A.). RNase treatment drastically reduced the fluorouridine signal, but not 
that of Y14 (Figure 3.11 B). Similar observations were made with eIF4AIII (Figure 3.11 C-
D). Therefore, these observations indicate that the EJC core proteins are not primarily 
recruited to transcription sites by binding nascent RNA. However, it is feasible that the 
recruitment of these proteins at these sites occur via other proteins present at these sites, or 











Figure 3.11 FUrd labelling indicates EJC proteins is not associated with nascent mRNA 
(A) Top panel shows double immunostaining with anti-Y14 and anti-BrdU and (C) anti-
eIF4AIII and anti-BrdU in the polytene chromosome.  The Y14, eIF4AIII and FUrd signals 
are present at most transcription sites in the absence of RNase. Anti-Y14, anti-eIF4AIII and 
anti-BrdU were detected with a FITC-conjugated secondary antibody (green) and Alexa 
Fluor 647-conjugated secondary antibody (red signal).  Bottom (B) and (D) panel shows that 
following treatment with 1 µg/µl RNase A, the Y14 and eIF4AIII signals persist, whereas 
FUrd signal has gone from transcription sites, seen more clearly in merged channels. All the 
images were also prepared with DAPI to indicate DNA. Images were captured with an 




3.2.10 EJC core components are recruited at transcription sites independently of 
introns 
 
One of the key predictions of current models is that EJC proteins bind mRNA after splicing. 
To test this prediction in vivo, I used the polytene chromosome on which specific intron and 
intronless transcription sites can be cytologically mapped. Well characterised intron-less loci 
are the heat shock genes and heat shock generates prominent puffs at these loci. A puff is a 
highly transcribed decondensed region of the chromosome which appears as bulge at a 
specific location of the chromosome. The most apparent heat shock puffs are at cytological 
positions 87A and 87C, both of which encode the heat shock protein 70 (Hsp70) and both do 
not have introns.  Other prominent heat-shock puffs are visible at 93D and 95D (Lis et al., 
1981). 95D encodes heat shock protein 68 (Hsp68) and also has no introns. 93D on the other 
hand is an intron-containing gene which encodes the long non-coding RNA (hsr-ω-n).  
Immunostaining shows that all three EJC core proteins (Y14, MAGO and eIF4AIII) are 
recruited to the intron containing 93D region, as well as also at the intron-less 87A, 87C and 
95D regions (Figure 3.12 A, B & C). In summary, recruitment of EJC proteins at heat shock 
loci, which are characteristically intron-less, indicates that their association does not depend 











Figure 3.12 EJC proteins are recruited to both intron-containing and intron-less genes.  
(A) Larvae were heat shocked at 37⁰C for 45 minutes and squashed polytene chromosomes 
were immunostained with anti-Y14 and hyperphosphorylated RNA Pol II
Ser2
 (H5). Y14 was 
subsequently detected with a FITC-conjugated secondary antibody (top-right panel, green 
signal) and Pol II with a Cy3-conjugated secondary antibody (top-left panel, red signal). 
Arrows (yellow) indicate recruitment of Y14 and Pol II
Ser2
 at the heat shock loci 87A & 87C, 
93D, and 95D respectively. (B) & (C) Immunostaining with MAGO and eIF4AIII shows a 
similar pattern of recruitment at all mentioned heat shock loci. All samples were also stained 
with DAPI (blue) and the colocalization signal is more apparent in the merged channels of 





3.2.11 Transcription dependent recruitment of EJC components at ecdysone induced 
puffs  
 
To assess further the transcription dependence of the EJC association with chromosomal loci, 
I studied the association of EJC proteins with two well-known puffs, 74EF and 75B, at which 
transcription is induced by ecdysone. Ecdysone is a Drosophila moulting hormone produced 
from prothoracic glands of these insects, and has a role in metamorphosis by inducing 
transcription of specific genes (Truman and Riddiford, 2002). Ecdysone directly induces 
transcription of 74EF and 75B, which are two of the longest Drosophila genes at 60 kb and 
108 kb respectively (Burtis et al., 1990; Segraves and Hogness, 1990). Both genes have very 
long introns, the largest intron for 74EF is about 30 Kb and for 75B is 60 Kb. As a 
consequence, it takes about 60 minutes for 74EF and 90 minutes for 75B to complete  
transcription at the estimated rate of 1.1kb/minute and for the first mature mRNA to be 
produced (LeMaire and Thummel, 1990). The presence of very long introns provides a good 
model for studying the recruitment of the EJC at these gene loci. Salivary glands were 
dissected from mid-3
rd
 instar larvae and treated with ecdysone for 1 hr before fixation. 
Immunostaining was carried out with EJC core components and the same squash was also 
stained for Pol II
Ser2
. A clear enrichment in the signal was observed at both the 74EF and 75B 
loci for all three EJC proteins, which colocalizes well with Pol II
Ser2
 (Figure 3.13 A).  
Notably, the signal intensity for the EJC core proteins at the 75B locus is higher compared to 
74EF. This might suggest that EJC recruitment at these two loci behaves differently. Binding 
of EJC proteins at both 74EF and 75B puffs further indicates that their recruitment is 
transcription-dependent. As predicted from an earlier study, the association of the EJC occurs 
after splicing, therefore recruitment of EJC proteins at these loci does not confirm whether 
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this recruitment occurs at the beginning of transcription with Pol II
Ser2
. As mentioned earlier, 
genes at both of these loci contain a very long intron, therefore, they take a longer time to 
produce the first mature mRNA. To further address the possibility of whether there is delay in 
the recruitment of Y14 at these loci I performed a time course ecdysone treatment in parallel 
with RNA Pol II
Ser2
. Prior to adding ecdysone, there was no Y14 recruitment at either loci, 
however, after 15 min the Y14 signal accumulates at the 75B locus and a very weak signal is 
seen at the 74EF loci, in parallel with Pol II
Ser2
 (Figure 3.13 B).  After 30 minutes, 1 h and 2 
h, the enrichment of Y14 increases at both loci, but particularly at 75B. The results of the 
above observations suggest that the recruitment of Y14 occurs as early as after 15 min 








Figure 3.13 EJC proteins recruitment is transcription dependent   
(A) Salivary glands were treated with 1µM ecdysone for 1 h, the squashed polytene 
chromosome was immunostained with anti-Y14, anti-MAGO and anti-eIF4AIII, which were 
subsequently detected using a Cy3-conjugated secondary antibody (red). Arrows indicate 
recruitment of all three EJC proteins (left panels) on the ecdysone induced 74EF and 75B 
puffs. Middle panels show the DAPI images (blue), and right panels are the merged red and 
blue channels. (B) Time interval recruitment of Y14 (left panel) and Pol II
Ser2
 (right panels) 
on ecdysone-induced puffs (74EF and 75B) with a no ecdysone control in the top panels. Y14 
was detected with a FITC-conjugated secondary antibody (green signal) and Pol II
Ser2
 with a 
Cy3-conjugated secondary antibody (red signal). The images were taken under a standard 




3.2.12 Y14/MAGO might regulate expression of ecdysone induced genes 
 
Having observed that EJC proteins associate with the 75B and 74EF puffs upon ecdysone 
induction, the question remained as to what their function was at these sites. To investigate 
further, I knocked down both Y14 and MAGO by RNAi in S2 cells. As previously shown, 
knockdown is efficient as both transcript and protein levels are drastically reduced (Figure 
3.9). In this later experiments we also observed EJC recruitment at the BR-C puff, upon 
ecdysone treatment (Figure 3.14 A). BR-C is a protein-coding gene with a long intron. 
Transcription of all three genes is rapidly induced upon ecdysone treatment in S2 cells; the 
induction reaches its highest peak after 2 h incubation (optimization data not shown). I 
observed that upon knockdown of either Y14 or MAGO, the transcript levels of 75B and BR-
C were significantly increased compared to control S2 cells upon ecdysone induction (Figure 
3.14 C). Notably, the level of this enhanced induction seems to correlate negatively with the 
level of of Y14 and MAGO at the gene, this is most apparent at 75B, which is the more 
affected than 74EF, yet shows higher levels of Y14 and MAGO. The data therefore suggest 
that the Y14/MAGO  heterodimer might act as a transcriptional repressor specifically of the 









Figure 3.14 Y14 and MAGO effects the expression of ecdysone-induced genes  
(A) Immunostaining with Y14 and MAGO of polytene chromosomes treated with 1 µM 
ecdysone, subsequently detected using a Cy3-conjugated secondary antibody (red). Arrows 
show the recruitment of Y14 and MAGO at BR-C loci. Middle panels indicate DAPI and 
rightmost panels are the merged images of DAPI and red channels. (B) Schematic 
representation of 74EF, 75B and BR-C genes, where arrows (black) indicate the location of 
primer pairs used for real-time RT-PCR (see Appendix II for list of primers, S-50 to S-55). 
(C) qRT-PCR was used to measure the transcript levels of 74EF, 75B and BR-C genes upon 
knockdown of Y14 and MAGO in S2 cells.  The fold enrichment method was used for 
calculation and normalized to reference control RpL32. Error bar indicates the standard 
deviation between the three biological repeats. (**) indicates statistically significant 
difference (P=0.001) between the control and Y14 RNAi treated sample, whereas, (*) denotes 
the difference between control and RNAi treated samples is insignificant (P>0.05), (see 




3.2.13 ChIP-seq data indicates recruitment of Y14 predominantly at transcription start 
sites  
 
To gain more detailed information on the distribution of the EJC throughout the genome, I 
carried out chromatin immunoprecipitation (ChIP) followed by high-throughput DNA 
sequencing (ChIP-seq). ChIP-seq is a widely used advanced technique to analyse the 
interaction between protein and DNA and is followed by DNA sequencing to map the 
binding sites of protein throughout the genomic region. ChIP experiments were performed 
with Drosophila S2 cells. Before performing ChIP, I optimized sonication conditions of the 
samples (see Material and Methods). ChIP experiments were carried out for all three EJC 
core factors, Y14, MAGO and eIF4AIII. However, only the Y14 antibody performed well 
and produced informative sequencing data (the sequencing and its analysis was carried out in 
collaboration with Dr. Paul Badenhorst at the Institute of Biomedical Research (IBR), and 
Aditi Kanhere in our school here at University of Birmingham, UK. Unexpectedly, ChIP-seq 
analysis revealed enrichment at transcription start sites (Figure 3.15 A & B).  Similar 
analysis, using the Cis-regulatory Element Annotation System (CEAS) also shows that Y14 
associates particularly at the promoter region of the gene (Figure 3.15 C & D). As an 
example, the enrichment at the TSS is apparent at the super sex comb gene (sxc) (Figure 3.15 
E). This data might explain why the Y14 signal at the chromosomes is resistant to RNase 
treatment; Y14 might be recruited to transcription sites directly or indirectly via an 
interaction with either DNA or DNA associated proteins. This analysis identified a list of 
putative Y14 associated genes, which includes both protein-coding and other RNA coding 
genes. Notably, the protein associates with intron-less genes (see Appendix VIII), consistent 
with the pattern on the polytene chromosomes which showed that Y14, similarly to the other 










Figure 3.15 Y14 is associated with transcription start sites (TSS) 
(A) & (B) Enrichment of Y14 across the whole genome body, indicates Y14 mainly 
associated at the transcription start sites. Plots were produced using next generation 
sequencing plot (ngs.plot, https://code.google.com/p/ngsplot/). (C) & (D) Plots showing Y14 
enrichment at either the promoter region or downstream of the TSS. Plots were produced 
using the Cis-regulatory Element Annotation System (CEAS) by Dr Aditi Kenhere. (E) A 
snapshot of a reference gene, sxc, in which Y14 enrichment at TSSs is apparent, indicated by 
the arrow. Chip-seq was carried out in two biological replicates, and each time the Y14 peak 




  3.3 Discussion  
 
Based on the contemporary model, the association of the EJC at spliced junction occurs 
simultaneously with splicing. Pre-mRNA splicing is typically co-transcriptional in 
Drosophila (Khodor et al., 2012); I therefore took advantage of the polytene chromosomes to 
gain insights into why the EJC seems to associate only with a subset of transcripts in 
Drosophila (Sauliere et al., 2010). The core EJC proteins Y14, MAGO, and eIF4AII localize 
mostly to the nucleus in mammalian cells (Baguet et al., 2007; Custodio et al., 2004; The 
Human Protein Atlas - www.proteinatlas.org). In Drosophila, the proteins also appear to be 
mostly nuclear in the cells analysed, however, as demonstrated by the oskar mRNA 
localization studies cited earlier, in the oocyte they are most abundant within the cytoplasm.  
I reported here that the EJC proteins are present in both the nucleus and the cytoplasm in 
salivary glands. Quantitative estimation to compare the nuclear and cytoplasmic levels of all 
three EJC proteins in Drosophila S2 cells  found the proteins to be equally distributed 
between the two compartments. To assess their distribution in the nucleus more directly, I 
carried out indirect immunostaining and report that the core EJC proteins Y14, MAGO and 
eIF4AIII associate with transcription sites of the Drosophila polytene chromosome. This 
localization with transcription sites is confirmed by double-immunostaining of the EJC 
proteins and PolI
Ser2
. This association with transcription sites was also observed using 
transgenic flies expressing tagged version of these proteins. My observation shows a 
complete overlap of the Y14 and MAGO signals, consistent with these proteins forming a 
stable heterodimer in vitro (Lau et al., 2003). The Y14 and MAGO signals are expected to 
match that of eIF4AIII at transcription sites, however, I found the distribution of eIF4AIII 
poorly correlates with that of Y14 and MAGO. This difference in staining pattern is more 
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apparent with parallel PolI
Ser2 
immunostaining, in which eIF4AIII is well colocalized with  
PolI
Ser2
, whereas, Y14 and MAGO signals are either absent or weak at intense PolI
Ser2 
sites. 
Specifically, double immunostaining of tagged eIF4AIII and endogenous Y14 further verified 
that there are sites at which the eIF4AIII signal is strong but Y14 is absent. Knockdown of 
Y14 also completely eliminated MAGO from transcription sites, while MAGO knockdown 
only partially reduced Y14. This suggests that Y14 can be recruited at transcription sites 
independently of MAGO. Y14 or MAGO knockdown does not have visible phenotypic 
effects, however, knockdown of eIF4AIII drastically impairs the growth of glands. This 
observation indicates that eIF4AIII might have additional roles, which are independent of 
EJC assembly. The observation that, after RNase treatment, EJC signals remain at 
transcription sites, suggests that EJC proteins might indirectly contact chromatin or DNA-
associated proteins. An unexpected finding is the recruitment of all EJC proteins at heat 
shock gene loci (87A & 87C). An association of EJC components at these loci further 
concludes that their association does not depend on the intronic features of genes, as these 
genes do not have introns. Moreover, EJC recruitment was also observed at other heat shock 
loci, for instance at 95D, which encodes heat shock protein 68 (Hsp68) and also has no 
introns, and the 93D region that encodes non-protein coding gene hsr-ω-n (Lakhotia and 
Tapadia, 1998). Similar observations were made with ChIP-seq of Y14, which showed that 
this protein associates with genes both with or without introns. This latter analysis also 
showed a preferential association with transcription start sites, suggestive of a role for Y14 at 
the promoter. My observations contradict previous conclusions that EJC association is 
splicing-dependent in Drosophila. Additionally, I show evidence that Y14/MAGO 
knockdown affects expression of ecdysone inducible genes, suggesting a role for these 









Evidence from past indicates that NMD may occur in the nucleus. NMD is a strictly 
translation dependent process, and the ribosome is the only cell component capable of 
reading the mRNA coding sequence and allowing recognition of a premature translation 
termination codon (PTC). Therefore, ribosomes may be functional in the nucleus. Here I 
describe a side project of my PhD in which I aimed to visualize ribosomal proteins and 
ribosome activity at transcription sites of the polytene chromosomes, following a strategy 
similar to that used for EJC proteins (Chapter 3). Firstly, to investigate whether ribosomal 
proteins are present at transcription sites, I used several transgenic Drosophila lines, that 
endogenously express yellow fluorescent protein (YFP)-tagged ribosomal proteins, to analyse 
their sub-cellular localization. This analysis confirmed that ribosomal proteins (RPs) 
accumulate in both the cytoplasm and the nucleus, and associate with transcription sites on 
polytene chromosomes, which was consistent with that previously reported (Brogna et al., 
2002). Identification of RPs at transcription sites is not sufficient to distinguish between fully 
assembled translating ribosomes and ribosomal proteins undertaking translation-unrelated 
functions. To differentiate between the two, I applied the ribopuromycylation (RPM) 
technique recently described for mammalian cells, which allows visualisation of translation 
(David et al., 2012). By using this technique, I found evidence of ribosomal activity at 
transcription sites on Drosophila polytene chromosomes. These findings indicate that nascent 
RNAs are translated, suggesting that there is a link between ribosomal scanning and RNA 
processing. This observation is consistent with the view that NMD may occur co-
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transcriptionally. To assess this hypothesis directly, we used antibodies against endogenous 
UPF1, a key NMD factor, to determine its presence on the polytene chromosomes. Notably, I 
found that UPF1 associates with majority of transcription sites.  In summary, the data provide 
evidence that both ribosomes and UPF1 are at transcription sites. These observations are 




























4.2.1 Characterization of YFP tagged ribosomal protein expression in salivary glands 
 
Transgenic lines carrying YFP tagged ribosomal proteins used in this study were received 
from Drosophila Genomics and Genetic Resources (DGGR), Kyoto Stock Centre (see 
Appendix III) (www.dgrc.kit.ac.jp). These trap lines carry the YFP coding region inserted 
into an intron of an endogenous gene, thus keeping the endogenous promoter activity (Morin 
et al., 2001). The YFP trapping cassette was inserted using a construct based on the 
piggyback transposable element and it was flanked by splice acceptor (SA) and donor sites 
(SD)(Figure 4.1A) (More details can be found at 
http://kyotofly.kit.jp/stocks/documents/CPTI.html). These constructs produce chimeric 
proteins in which YFP is added at variable positions of the trapped protein, therefore 
providing a potentially good system to target proteins in tissues. Detailed information about 
each fly line and their source is given in Table 4.1, while a schematic diagram of each 

























































































Table 4.1 YFP tagged transgenic lines. 
Details of the transgenic lines RpS9-034, RpS9-504, RpL10Ab and RpL 41 which were used 




Figure 4.1 Schematic representation of YFP tagged ribosomal proteins.   
(A) Schematic of the principle of the YFP protein trap strategy in which the YFP coding 
sequence, flanked by acceptor (SA) and donor (SD) splice sites, gets randomly inserted into 
an intron. (B) A simplified representation of different tagged RpL41, RpL10Ab, RpS9 034, 
and RpS9 504 proteins which are expressed from their endogenous promoter. Black line 
indicates an intron, whereas boxes represent exons. Length of each gene and location is 
indicated by the nucleotide base number (source flyBase).  
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4.2.2 Confirmation of the transgene inserts of each fly strain 
 
To validate the transgenic lines by PCR, primers were designed to amplify part of the YFP 
sequence and downstream exons (Figure 4.2 A). This work was done in collaboration with 
Sarah Taylor (a Masters student in our lab). Fly genomic DNA was used as a template and 
PCR products were visualised by agarose gel electrophoresis (Figure 4.2 B). PCR of RpL41-
YFP and RpL10Ab-YFP produced the right size fragment of 189 bases and 1393 bases 
respectively, confirming the right constructs. However, line 034 of RpS9-YFP produced a 
larger fragment than expected which was 740 bases and no PCR products were amplified for 
line 504 of RpS9-YFP, suggesting the latter does not carry the desired construct (4.2 B). 
Having confirmed the fragment size by PCR, we also further verified the tagging construct of 
RpL41-YFP and RpL10Ab-YFP and RpS9-YFP (034) by DNA sequencing. Corresponding 
PCR fragments were gel purified and sent to GATC Biotech Ltd (London) for sequencing. 
The sequence was also matched with a BLAST search for all transgene constructs 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) (see Appendix V). Confirmation of the constructs 







Figure 4.2 Confirmation of transgene constructs by gel electrophoresis. (A) 
Representation of primer location within the each construct. (B) PCR products were run in 
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1% agarose gel. Lane 1 indicates 1kb DNA ladder whereas lanes 2 and 3 show PCR products 
of RpL41-YFP and RpL10Ab-YFP. Lanes 4 and 5 represent PCR products of RpS9 034-YFP 
and RpS9 504-YFP. 
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4.2.3 Localization of ribosomal proteins in whole salivary glands  
 
I visualized YFP tagged ribosomal proteins in the salivary glands of 3rd instar larvae. 
Microscopy imaging of RpL41-YFP shows a strong YFP signal in the nucleus, particularly 
intense in the nucleolus, and a relatively weaker signal in the cytoplasm. Instead, RpL10Ab–
YFP, as expected for a RP shows a strong signal in both the cytoplasm and the nucleolus, but 
a weak signal in the rest of the nucleus. The RpS9-YFP (034) lines show a signal mostly in 
the cytoplasm with no apparent nucleolar signal. The second RpS9-YFP (504) line produced 
no fluorescent signal above background (Figure 4.3 A). After these initial results, I focused 
on better characterizing the subcellular localization of RpL41 as it shows an unexpectedly 
strong signal in the nucleus. RpL41 is a very small protein (only 25 amino acid) that it is 
associated with the intersubunit surface of the 80S (Klinge et al., 2012). In Drosophila, the 
RpL41 gene is present as a single copy in the genome and is essential for viability (Marygold 
et al., 2007). Confocal imaging of RpL41-YFP confirmed that the signal is most concentrated 
in the nucleus, particularly in the nucleolus (Figure 4.3 B). We published these observations 
along with similar data, which show that other fluorescently tagged ribosomal proteins also 
accumulate in the nucleus and are present at transcription sites of the polytene chromosome 













   Figure 4.3 Expression of endogenously tagged ribosomal proteins in salivary glands. 
(A) Top left panel (I) shows the subcellular localization of YFP tagged RpL41 in salivary 
gland cells. Panel (IV) indicates expression of YFP-RpL10Ab and bottom two panels (VII & 
X) show localization of RpS9 (504) and RpS9 (034) under native promoter control. Middle 
panel shows DAPI staining to indicate the nucleus and the right panel shows the merged 
channels of DAPI and YFP. All images were taken using an epifluorescence microscope with 
a 40X objective. (B) Top left panel shows a confocal section of RpL41-YFP fluorescence 
signal in salivary gland cells. The nucleus is stained with DAPI in the middle panel while the 
top right panel is a merged image of DAPI and YFP fluorescence. The bottom panel shows a 
magnified view of a single cell in the top panel, with the arrow indicating the nucleolus. 




4.2.4 Endogenously tagged RpL41-YFP associates with transcription sites  
 
To test directly whether RpL41 associates with transcription sites, I stained the polytene 
chromosomes for YFP. However, this produced a very faint signal at the chromosome which 
was difficult to interpret (Figure 4.4 A). To further assess the association of RpL41 with the 
chromosomes, I analysed polytene chromosomes squashed in native conditions to preserve 
YFP fluorescence (in the standard procedure, the presence of acetic acid destroys fluorescent 
signals). Although it is difficult to achieve good chromosomal spreads with this procedure, 
these squashes clearly show that RpL41-YFP specifically associates with interband regions 
(Figure 4.4 B) (see Materials and Methods for detailed information on this acid-free 
squashing procedure). These squashes were also prepared with DAPI to stain the DNA and it 
is clear from the merged channel that tagged RpL41-YFP associates with transcription sites 




Figure 4.4 Tagged RpL41 associates with transcription sites of the polytene chromosome 
Top row (A) shows a polytene chromosome from a strain expressing RpL41-YFP, indirectly 
immunostained with an anti-GFP primary antibody, which was subsequently detected with a 
Cy3-conjugated secondary antibody. DAPI staining is shown in the middle panel, while the top 
right panel is a merged image of Cy3 and DAPI. (B) A polytene chromosome under native 
conditions shows the YFP fluorescence signal corresponding to YFP-RpL41 in the top left 
panels, whereas the bottom left panel is a merged image of the YFP and DAPI channels. The 
top rightmost panel is a magnified view of the box indicated in the main image; lines denote 
the fluorescence signals in the interband positions and that of DAPI in the bottom right panels. 




4.2.5 Ribopuromycylation allows visualisation of translation sites in vivo 
 
To assess whether translating ribosomes are present in the nucleus in Drosophila, I utilised a 
new technique known as ribopuromycylation (RPM), which was first used to detect 
translation sites in mammalian cells (David et al., 2012) (Figure 4.5). Puromycin is an 
aminonucleoside antibiotic, mainly derived from the Streptomyces alboniger bacterium and is 
an analog of the 3' end of an aminoacylated tRNA (Yarmolinsky and Haba, 1959). 
Puromycin enters the A site of the translating ribosome and is incorporated into the newly 
synthesized peptide chain, causing its premature release (Tscherne and Pestka, 1975). It was 
reported by David and Collaborators (2012) that elongation inhibitors such as emetine or 
cycloheximide (CHX) prevent the release of puromycylated peptide chains, which remain 
bound to the ribosome. An antibody specific to puromycin can thus be used to detect the 
translating ribosome in both fixed and permeabilized cells  (David et al., 2012). The RPM 
technique was successfully applied by David and Collaborators (2012) to visualize translating 
ribosomes, which notably were seen both in the cytoplasm and in the nucleolus of 





Figure 4.5 Schematic of the RPM procedure 
Polysomes were immobilized on mRNAs by one of two elongation inhibitors, CHX or 
emetine. Puromycin was added, which is then incorporated into nascent polypeptide chains 





4.2.6 Puromycylation observed in salivary glands and S2 cells 
  
To test the feasibility of the puromycylation technique, I used both salivary glands and S2 
cells, which were treated with puromycin alone, or in combination with translation elongation 
inhibitors and other translation inhibitors, as described for mammalian cells (David et al., 
2012). My Western blotting results clearly indicate that puromycin incorporation was 
observed in both S2 cells and salivary glands, in either the presence or absence of translation 
inhibitors drugs, but no signal was observed in the absence of puromycin, which further 
indicates the specificity of the antibody in Drosophila (Figure 4.6).  Moreover, in the 
presence of translation initiation inhibitors such as harringtonine or anisomycin, puromycin 
incorporation was significantly reduced compared to the untreated samples, which is as 
expected and as shown by David et al. (2012). However, treatment with emetine reduces 
puromycylation in both S2 cells and salivary glands, suggesting that the drug can partially 





Figure 4.6 Western blot shows puromycin incorporation in both S2 cells and salivary 
glands 
(A) The top panel shows puromycin incorporation in salivary glands.  Lane 1 shows a sample 
treated with 50 µg/ml puromycin only and lane 2 with both 50 µg/ml puromycin and 100 
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µg/ml emetine. Lanes 3 and 4 were pretreated with 2µm harringtonine and 20 µg/ml 
anisomycin followed by puromycin. Lane 5 represents a no drug control to check the 
specificity of the antibody. (B) Bottom panel: the same drug treatments were used in S2 cell 
extracts (see Materials and Methods for details).  The same membrane was also re-probed 
with tubulin which was used as a loading control for both Western blots. (This figure were 





4.2.7 Puromycin incorporation in intact whole salivary glands  
 
To assess whether the RPM technique can be used to detect translating ribosomes in vivo, 
intact salivary glands were dissected from mid-3rd instar larvae and pre-treated with different 
drug combinations as in S2 cells. The results suggest that puromycylation occurs both in the 
cytoplasm and in the nucleus (Figure 4.7 A).  In the larger cells of the lobe, puromycylation is 
also observed around the chromosomes. The signal is also apparent in the nucleolus, 
particularly in the smaller cells that make the proximal portion of the gland.  (Figure 4.7 B). 
Notably, the relative signal intensity of the nucleus and nucleolus is higher after treatment 
with emetine, consistent with RPM reporting translation sites. Glands pretreated with the 
translation initiation inhibitor harringtonine, showed drastically reduced puromycylation, 








   Figure 4.7 Puromycylation in intact whole salivary glands 
The first panel, Figure (A), shows a confocal image of salivary glands treated with puromycin 
and emetine and subsequently immunostained with an Alexa 488 conjugated 2A4 
monoclonal antibody. Arrows indicate puromycin incorporation in the nucleolus. The middle 
panel shows glands treated with puromycin only and the last panel demonstrates pre-
incubation with harringtonine followed by puromycin and emetine incubation. (B) Figure 
shows a magnified image of salivary gland cells treated with puromycin and emetine, where 
arrows indicate a ring-like structure around the nucleolus. All glands were also 
counterstained with DAPI to visualize the nucleus. The right panels show a merged image of 
the DAPI and the green channel. All images were taken with a Leica confocal microscope 





4.2.8 Incorporation of puromycin at polytene chromosome transcription sites  
 
To address the issue whether ribosomes are present at transcription sites, I applied the RPM 
technique to the polytene chromosomes (see Material and Methods). Puromycin 
incorporation was detected at the chromosomes and particularly in the interband regions 
(Figure 4.8 A). Although a faint signal was also observed in the band region (transcriptionally 
inactive region of chromatin) this was mostly weak compared to the interband 
(transcriptionally active region of gene). Moreover, the signal was particularly intense at 
specific interbands (indicated by the arrow in Figure 4.8 A., magnified insets). The signal 
appears to be specific at these sites, as in the absence of puromycin there was no such signal 
(shown below). Also I noted that treatment of the glands with aurintricarboxylic acid (ATA), 
an RNase inhibitor, significantly increased the intensity of the signal at interband regions (see 
Materials and Methods). In addition, pre-treatment of the glands with the DNA intercalating 
drug actinomycin D, significantly intensifies the signal at interband regions particularly at 
transcription puffs (highly active in transcription) (Figure 4.8 B). Furthermore, a weak 
puromycin signal was also observed around the nucleolus. To further test whether the signal 
is translation dependent, polytene chromosomes were pre-incubated with the translation 
initiation inhibitor harringtonine. Upon treatment with this inhibitor, the puromycin 
incorporation signal appears to be drastically reduced at interband regions (Figure 4.9). These 
results indicate that puromycin incorporation is translation dependent and is consistent with 
that observed in salivary glands and S2 cells in Western blotting. As mentioned above, the 
signal is RNase-sensitive: the addition of RNase inhibitors increases the puromycin signal 
and adding RNase completely abolishes it at the interband or puffs (Figure 4.9). The RPM 
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method provides evidence for the recruitment of actively translating ribosomes at 







Figure 4.8 Puromycin incorporation on transcription sites of Drosophila polytene 
chromosomes 
(A) Top panels show salivary glands pre-incubated with 50 µg/ml puromycin and100 µg/ml 
emetine. White arrow indicates puromycin signal at the interband position. (B) Glands were 
incubated with 100 µg/ml emetine, 50 µg/ml puromycin and 10 µg/ml actinomycin D (Act D) 
(see Materials and Methods for details). Direct immunostaining with an Alexa488-conjugated 
anti-puromycin antibody shows puromycin signal all over the chromosome, particularly 
intense at the interband position. Bottom panels show a magnified section indicated by a 
white square from the panel above, with strong puromycin signal indicated by the white 







Figure 4.9 Puromycin signal is translation dependent  
Immunostaining of chromosomes was performed as above. Top panel shows, 2 µM 
harringtonine was added for 30 minutes prior to incubation with puromycin, emetine and Act 
D. In the middle panel, 100 µg/ml RNase A was added to the first squashing step, prior to 
fixation, and the sample was incubated for 2 minutes at room temperature.  Puromycin was 
omitted in the control (bottom panel), in which only faint background fluorescence can be 





4.2.9 Generation of monoclonal antibodies against UPF1 and UPF2 of Drosophila  
 
To produce the antibodies against the UPF1 and UPF2, protein amino acid sequences were 
retrieved from FlyBase (Table 2.1 & 2.2, see Material and Methods, section 2.13) and 
specific regions were selected by the company Abmart.  Abmart uses its patented technology, 
Abmart Seal, which involves cloning of the selected epitopes into a specific vector to produce 
a recombinant protein incorporating several antigens. This is used for immunization of mice 
that then develop an immune response against the desired peptide, which is followed by 
production of hybridoma clones (a detailed description of the Abmart SEAL technology is 
given in Material and Methods, section 2.13). Twelve epitope sequences were selected for 


















Table 4.2 Twelve potential epitopes for UPF1  
Number Start End Peptide 
1 43 52 TSQSQTQNDQ 
2 85 94 DEPGSSYVKE 
3 1084 1093 PGGNKKTNKL 
4 342 351 HYVGELYNPW 
5 788 797 QYQGSLHSRL 
6 27 36 DTQPTQYDYR 
7 528 537 KSREAIDSPV 
8 60 69 SAGDSHPRLA 
9 1140 1149 SQQPELSQDF 
10 259 268 KPGIDSEPAH 
11 1060 1069 QTGNFSPGNS 








Figure 4.10 Prediction analysis of the UPF1 protein  
This graph gives an overall view of the protein structure and the location of the selected 
peptides. The x-axis indicates the amino acids number in the protein, and y-axis is the value 
of the algorithm where the higher score indicates the higher probability of generation of the 
antibody against that epitope. The scores of each 10mer epitope are plotted with a grey line. 
Selected epitopes are highlighted in blue on the graph. Hydrophobic residues are shown using 
red bars under the x-axis. This graph was taken from Abmart. 
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Table 4.3 Twelve potential epitopes for UPF2 
Number Start End Peptide 
1 1 10 MLANDSATTD 
2 29 38 EGDNDNDIDT 
3 13 22 VSTPPSSRKD 
4 1220 1229 QKPNKHKFKH 
5 445 454 DDPPSTTSDT 
6 960 969 KTTNNAQDPS 
7 703 712 SSKREPMVRP 
8 999 1008 VSGQEQDQSN 
9 461 470 EEQPTTPVAA 
10 903 912 HPVFSKTENT 
11 1098 1107 PNQDGTPGSP 









Figure 4.11 Prediction analysis of the UPF2 protein 
This graph gives an overall view of the protein structure and the location of the selected 
peptides. The x-axis indicates the amino acids number in the protein, and y-axis is the value 
of the algorithm where the higher score indicates the higher probability of generation of the 
antibody against that epitope. The scores of each 10mer epitope are plotted with a grey line. 
Selected epitopes are highlighted in blue on the graph. Hydrophobic residues are shown using 
red bars under the x-axis. This graph was taken from Abmart. 
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4.2.10 Western blot analysis of UPF1 ascites identified three potential clones specific for 
UPF1  
 
18 UPF1 hydridoma clones were received from Abmart (see Appendix VII for a list of all 
ascites and clone ID numbers) and we tested them for their specificity against UPF1 by 
Western blotting of Drosophila S2 cell extracts. The results showed a band of the expected 
size with several of the antibody clones, however, most of them also showed nonspecific 
bands. I chose three clones that showed minimal cross-reactivity with other proteins (Figure 
4.12). These three clones were renamed based on the Western blot lane number: UPF1-1 (ID-
10108-1-1M1/1C13-2_121113, epitope peptide 2, see table 4.2), UPF1-3 (ID-10108-1-
7M1/7D17-11_121114, epitope peptide 12, Table 4.2) and UPF1-16 (ID-10108-1-
7M1/7B12-12_121120, epitope peptide 10, Table 4.2). Based on these initial Western blot 
data, we (Dr. Brogna) requested Abmart to purify the above three monoclonal antibodies for 
further testing. Unfortunately, I was unable to detect any band of the correct molecular size 
for the UPF2 protein from any of the UPF2 ascites in the Western blot (see Appendix VI for 







Figure 4.12 Western blotting of S2 cell extracts with different UPF1 hybridoma clones 
(A) S2 cell extracts were immunoblotted with UPF1-1 to UPF1-8 ascites, in which two 
potential clones,  UPF1-1 and UPF1-3  (lanes 1 & 3, marked by asterisk), identified by a band 
of the right molecular size (129.94 kDa) with no background signal, indicating the specificity 
against endogenous UPF1. Lanes are labelled with each UPF1 ascite’s ID clone number. (B) 
Western blot of UPF1-9 to UPF1-18 ascites. Only UPF1-16 (lane 16, marked by asterisk) 
shows a band of the correct molecular size, corresponding to endogenous UPF1, although 
with some background signal of other molecular sizes. 
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4.2.11 Validation of potential UPF1 monoclonal antibodies 
 
To further confirm that the three UPF1 antibodies we have selected can specifically detect the 
correct protein, I expressed GFP-tagged UPF1 in S2 cells (see Appendix IV) and assayed 
whole cell lysates by Western blotting. As expected, two bands were detected, one 
corresponding to endogenous UPF1 and the other to UPF1-GFP. All three UPF1 antibodies 
gave similar results. The top band corresponds to GFP-tagged UPF1 and the lower band is 
specific to endogenous UPF1 (Figure 4.13). The data thus show that all three monoclonal 






Figure 4.13 Western blot analysis shows that UPF1 ascites detect both endogenous 
UPF1 and GFP-tagged UPF1  
(A) S2 cells were transfected with UPF1-GFP and immunoblotted with UPF1-1 ascites in 
parallel with a control S2 cell extract. Lane 1 shows detection of both the expressed UPF1-
GFP (156.94 kDa) (top) and endogenous UPF1 (bottom), whereas in lane 2 only endogenous 
UPF1 is detected. (B) and (C) UPF1-3 and UPF1-16 ascites were immunoblotted in a similar 
way, and both UPF1-GFP and endogenous UPF1 (lane 1 of (B) and lane 2 of (C)) were 
detected in the transfected extract, but only endogenous UPF1 was detected in the control S2 
cell extract (lane 2 of (B) and lane 1 of (C)). 
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4.2.12 Purified UPF1 antibodies show specificity against endogenous UPF1  
 
The first batch of UPF1-1, UPF1-3 and UPF1-16 antibodies (Table 4.4) received from 
Abmart were tested, after Protein A/G affinity chromatography and checked again by 
Western blotting (Figure 4.14). These purified antibodies produced similar results as the 
ascites but UPF1-1 sensitivity was low as only the UPF1-GFP band could be detected and 
UPF1-16 produced higher background than with the ascites. Two of the antibodies were 
purified again by Abmart. In this second batch (Table 4.5), UPF1-16 showed good specificity 
against both UPF1-GFP and endogenous GFP with little background signal (Figure 4.15), 


















































Figure 4.14 Western blot analysis of the first batch of purified UPF1 antibody detected 
endogenous UPF1 as well as GFP-tagged UPF1  
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(A) S2 cells were transfected with UPF1-GFP and immunoblotted with the UPF1-1 antibody 
in parallel with an S2 cell extract control. Lane 1 shows endogenous UPF1 and lane 2 shows 
both UPF1-GFP (156.94 kDa) (top) and endogenous UPF1 (bottom). (B) and (C) UPF1-3 and 
UPF1-16 antibodies were used in a similar way.  These antibodies detected both UPF1-GFP 
and endogenous UPF1 (lane 1 of (B) and lane 3 of (C)) in the transfected cell extract while 
only endogenous UPF1 in the control S2 cell extract (lane 2 of (B) and lane 2 of (C)). 
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Figure 4.15 Western blot analysis of the second batch of purified UPF1 antibodies 
showed detection of both endogenous UPF1 and UPF1-GFP  
(A) S2 cells were transfected with UPF1-GFP and immunoblotted with UPF1-1 and UPF1-16 
antibodies in parallel with a control S2 cell extract. The Western blot with UPF1-16 antibody 
showed detection of both endogenous UPF1 and UPF1-GFP in lane 1, while only endogenous 
UPF1 in lane 2 (control). Immunoblot with UPF1-1 antibody detected UPF1-GFP in lane 3 
but was unable to detect endogenous UPF1 in both lanes 3 and 4 (control).  
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4.2.13 UPF1 associates with most of the transcription sites of polytene chromosomes 
 
The core NMD factor UPF1 not only functions in the cytoplasm to degrade PTC-containing 
mRNAs, but also has a nuclear role in telomere maintenance and cell cycle progression in 
mammalian cells. Here, I used a similar approach to that used for investigation of EJC 
proteins, to visualize UPF1 at transcription sites, using the antibodies we developed. To 
visualize the UPF1 protein at transcription sites, indirect immunostaining was carried out 
with all three available antibodies: UPF1-1, UPF1-3, and UPF1-16. Staining with the UPF1-3 
and UPF1-16 antibodies showed a clear signal at polytene chromosomes (Figure 4.16). The 
signal is more specific to interband loci (transcriptionally active regions). Notably, the UPF1 
signal was present at most of the transcription sites and counterstaining with DAPI showed a 
weak signal at the interbands. Both the UPF1-3 and UPF1-16 antibodies show similar 
patterns.  Unfortunately, UPF1-1 did not show a clear signal around the chromosome (data 
not shown). The data from these results suggest that UPF1 associates with transcription sites 





Figure 4.16 UPF1 associated with transcription sites of Drosophila polytene 
chromosome. 
(A) Indirect immunostaining with the UPF1-16 antibody shows UPF1 recruitment at 
interband positions (top panel in red). The arrow indicates the nucleolus. DAPI is used to 
stain the banded regions of the chromosome (middle panel). The UPF1 signal is much clearer 
in the merged channel (right panel). (B) Indirect immunostaining with the UPF1-3 antibody, 
shows a similar pattern at interband regions as UPF1-16. Middle panel shows DAPI staining 
while the right panel is the merged image. UPF1 is detected using a Cy3 conjugated 
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4.2.14 UPF1 accumulates in the nuclei of salivary gland cells 
 
Whole salivary gland immunostaining was carried out with the UPF1-3 and UPF1-16 
antibodies. As described earlier, whole salivary glands have large cells with polytenic nuclei, 
therefore they provide a good model to localize proteins in the subcellular compartment, and 
also give less variation between samples compared to polytene chromosome squash 
preparations. Salivary glands were dissected from 3rd instar larvae and analysed using a 
standard immunostaining protocol (see Material and Methods). Both antibodies show a signal 
in both the nucleus and cytoplasm (Figure 4.17). However, signal intensity is higher in the 
nucleus compared to the cytoplasm and specifically around the chromosomes, as indicated by 
DAPI counterstaining. To test the specificity of the antibodies further, I performed 
immunostaining of chromosomes from UPF1 RNAi lines (S-308, Bloomington, see 
Appendix III). The UPF1 signal was drastically reduced at the polytene chromosome 
compared to that in wild-type larvae (Figure 4.18). In summary, these results indicate that the 
UPF1 antibodies we have generated are specific, and UPF1 is abundant in the nucleus as well 









Figure 4.17 Visualization of UPF1 in whole salivary glands  
(A) Confocal image of whole salivary glands stained with UPF1-16 showed a UPF1 signal in 
both the cytoplasm and the nucleus. The signal is much more intense in the nucleus compared 
to the cytoplasm, as also observed in the polytene chromosomes. The middle panel shows 
DAPI staining while the right panel is the merged image. (B) A similar signalling pattern was 
also observed by staining with the UPF1-3 antibody. Cy3 conjugated secondary antibody was 






Figure 4.18 UPF1 knock down reduced the UPF1 signal from chromosomal sites 
(A) Top left panel shows polytene chromosomes stained with UPF1-16 from wild-type 
larvae; the UPF1 signal is observed all over the chromosome, particularly at interband 
regions. This is much clearer in the merged channels (C). (B) DAPI staining of 
chromosomes. (D) Top right panel shows UPF1 RNAi lines (S-308, Bloomington, see 
Appendix III) which were crossed with the fkh-Gal4 driver, in which the UPF1 signal was 
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reduced from the chromosomal sites. (E) Middle panels show DAPI staining. (F) The UPF1 






Observations from the NMD field indicate that premature translation termination codons 
(PTCs) can be recognised while the transcript is still in the nucleus. NMD is a translation 
dependent process, and ribosomes are the only machinery able to scan the mRNA to 
recognize the PTC. If NMD were to take place in the nucleus, the expectation is that 
functional ribosomes and NMD factors will also be present in order for this scanning and 
PTC recognition to take place. Ribosomal proteins constitute an essential part of the ribosome 
and are also important for viability of all cell types. Therefore, I decided that a good starting 
point would be to localize tagged ribosomal proteins and their recruitment at transcription 
sites of the Drosophila polytene chromosome. Consistent with this view, here I report that 
analysis of several yellow fluorescent protein (YFP) -tagged ribosomal protein transgenic 
Drosophila lines, indicates that ribosomal proteins (RPs) accumulate in both the cytoplasm 
and the nucleus, specifically YFP-tagged RpL41. Moreover, the association of YFP-tagged 
RpL41 at transcription sites on polytene chromosomes further confirms their presence at 
these sites, which is consistent with that previously reported (Brogna et al., 2002). This result 
is also consistent with our report that several other fluorescently tagged ribosomal proteins 
are present at transcription sites in Drosophila polytene chromosomes (Rugjee et al., 2013). 
Although, it possible that the tagged ribosomal proteins observed are in a free state, and not 
incorporated into ribosomal subunits, my observations support the earlier conclusion that RPs 
might be recruited in the form of complexes at transcription sites (Brogna et al., 2002). The 
accumulation of YFP-tagged RpL41 in the nucleus, with the characteristic of nucleolar 
enrichment, and presence at transcription sites imply that these tagged RPs can be 
incorporated into ribosomes.  
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To assess whether there are translating ribosomes at these sites more directly, I applied the 
recently developed ribopuromycylation technique (David et al., 2012). The results of these 
experiments show puromycin incorporation at interband positions of highly transcribed 
regions of Drosophila polytene chromosomes. The puromycin signal seems to be 
transcription dependent, as RNase treatment depletes most of the signal from these 
transcription sites. In addition, puromycylation was also observed in intact salivary glands, 
mainly in the cytoplasm and nucleolus of smaller cells, and puromycylated peptides were 
observed around the chromosomes in larger cells. As reported earlier, following treatment 
with translation inhibitor drugs such as harringtonine, the signal appears to be drastically 
reduced, which suggests that the puromycin signal is translation-dependent, as previously 
concluded in mammalian cells by David et al 2012. These observations further suggest the 
presence of functional 80S ribosomes at these sites, providing additional evidence to support 
the possibility that PTC recognition can occur while the transcript is still nascent and that 
NMD may occur at the sites of transcription on newly synthesized mRNAs. Moreover, the 
observation that UPF1 is present at most of the transcription sites further strengthens the 
argument that NMD can occur in the nucleus. Future studies will have to investigate this 
further, and also test the alternative possibility that UPF1 is performing some other functions 
at transcription sites which could be unrelated to NMD. In addition, the antibodies we 
produced can be used for other experiments aimed at understanding how these protein 











As reviewed in the Introduction, the coupling between transcription and pre-mRNA splicing 
is an essential step of gene expression. Co-transcriptional splicing is the process in which 
introns are spliced out of the nascent pre-mRNA that is still attached to the RNA polymerase. 
This coupling between transcription and pre-mRNA splicing is important in splice site 
selection. Here I describe the development of an experimental system that allows 
visualization of pre-mRNA splicing and mRNP assembly directly at transcription sites. This 
system uses reporter constructs based on the medfly Ceratitis capitata Adh gene, which is 
evolutionarily distantly related to Drosophila melanogaster. The first reporter construct 
(which was available in the Dr. Brogna lab) produces an mRNA carrying one or more repeats 
of the sequence-specific RNA binding sites for protein (MS2) sequence in the 3’ UTR, which 
can be visualised by co-expression of fluorescently-tagged MS2 coat protein (MCP) that 
binds to the MS2 sequence with high specificity (Weil et al., 2010). The construct, denoted 
Adh-MS2 (Figure 5.1) (S-118, see Appendix III) is regulated by an ecdysone response 
element (ERE) in the promoter which enables its expression to be induced in the presence of 
ecdysone. Ecdysone is a steroidal prohormone whose increase in concentration induces the 
expression of protein coding genes. Moreover, this construct is also flanked by lac operator 
(lacO) repeats at the 5’end; the addition of the lacO repeats allows visualization of the locus 
160 
 
in cells expressing lac repressor tagged with GFP. A similar reporter construct was used to 
visualise spliced mRNA in which MS2 sequence was split between the 3’ end of exon 1 and 
the 5’ end of exon 2 which was denoted as Adh-split-MS2 (Figure 5.3).  
 
 Figure 5.1 Schematic representation of Adh-MS2 reporter constructs.  Reporter 
construct consists of two coding sequences (exons) of the medfly alcohol dehydrogenase 
(Adh) gene separated by an intron and flanked by 3’UTR containing MS2 binding sites. The 
promoter is regulated by an ecdysone response element (ERE) which is flanked by lacO 




5.2 Result  
5.2.1 Visualization of nascent RNA in Drosophila salivary glands 
 
To test whether the approach I described above would allow visualisation of nascent mRNA, 
I crossed different available strains expressing MCP-GFP (Appendix III) with flies carrying 
the reporter construct Adh-MS2. As expected, I observed that MCP-GFP clearly generates a 
strong green fluorescence signal in correspondence to a specific interband, which most 
probably corresponds to the nascent mRNA of the Adh-MS2 transgene (Figure 5.2). 
Although the GFP signal is visible throughout the nucleus, as a result of background 
fluorescence, the signal is much stronger in correspondence to a specific interband. This 
observation indicates that this reporter can be further used to visualise specific nascent RNAs 




Figure 5.2 Visualisation of a specific reporter nascent RNA in the nuclei of salivary 
glands Left panel shows images of salivary glands from larval progeny of a cross between 
the reporter Adh-MS2 (S-118, see Appendix III) and the MCP GFP line flies (S-240, ID 
7278, see Appendix III).  GFP signal is visualized as a single dot in the nucleus. The signal is 
more apparent in the magnified insets of the original image (marked with a white box) in the 
right panels. Arrow indicates specific chromosomal position with an intense GFP signal. 
However, GFP also accumulates all over the cell and its signal is stronger in the nucleolus 
(white arrow). Glands were counterstained with DAPI to stain DNA (middle panel). Bottom 
panels show merged channel of both GFP and DAPI. Images were taken using an 




5.2.2 Versatile gene reporter constructs allow visualisation of splicing 
 
Having demonstrated that the above system allows visualisation of nascent RNA, I wanted to 
test whether it’s feasible to specifically visualize spliced mRNA. To visualize spliced mRNA 
I used a transgenic line (Dr. Brogna lab, unpublished) carrying the Adh-split-MS2 construct 
(Figure 5.3), in which MS2 binding site was split between the end of the first and the 
beginning of the second exon. Therefore, a functional MS2 binding site is formed only upon 
ligation of the two exons, which can be visualized by co-expressing GFP or RFP-tagged 
MS2, as mentioned above. Additionally, the split Adh-MS2 reporter construct is flanked by 
ERE promoter at 5’ UTR. This system is therefore expected to be effective in visualizing pre-






Figure 5.3 Simplified representation of the split Adh-MS2 reporter construct.  The 
construct consists of Adh coding sequence split into two exons - each exon is flanked with 
two halves of the MS2 binding site. The Promoter is regulated by an ecdysone response 















5.2.3 Visualization of pre-mRNA splicing in nuclei of Drosophila salivary glands  
 
To visualize splicing, I examined different Drosophila lines carrying the split-Adh1-MS2 
construct (see Appendix III) at different chromosomal locations. I selected the best one by 
crossing them with MCP-GFP lines and inspecting which cross had the most defined GFP 
signal at the transgenic locus. The best Adh-split-MS2 line was then crossed again with the 
MCP-GFP line and salivary glands from 3rd instar larvae were used for in vivo imaging.  
Firstly, I examined glands which were not exposed to ecdysone in which, therefore, the 
expression of the reporter was not expected. In these glands, only background MCP-GFP 
signal was observed all over the cell, with particularly high intensity in the nucleolus (Figure 
5.4). Several glands were inspected but no specific chromosomal signal could be detected. 
Salivary glands were then treated with 1µM ecdysone for 2.30 h prior to dissection to induce 
expression. After ecdysone treatment, a strong signal was observed in correspondence to a 
single chromosomal band (Figure 5.4). As demonstrated by the DAPI counterstaining, the 
signal is located at an interband on the chromosome. These observations suggest that this 
signal is due to the presence of a nascent spliced mRNA at this locus. Thus, this system 
allows visualisation of co-transcriptional splicing and studying selective docking of proteins 




Figure 5.4 Visualisation of co-transcriptional splicing. Adh-split-MS2 line (S-90, see 
Appendix III) was crossed with MCP GFP Line (S-240. ID 7278, see Appendix III). The top 
left panel shows that there is no prominent chromosomal signal in the absence of ecdysone. 
Treatment with ecdysone (bottom panels) results in a prominent band at the chromosomes 
(arrow) which is shown clearer in the magnified inset showing a single nucleus. Another 
gland is viewed in the bottom right panel, which was similarly treated with ecdysone, as the 




5.2.4 Transgene visualisation using lacI-GFP 
 
To facilitate visualization of specific mRNPs in intact nuclei without the need of 
chromosome spreading, lacO repeats were added to the reporter gene as described above.  To 
verify the system, I combined lacI-GFP and MCP-RFP in order to be able to distinguish the 
locus and the mRNA signal, respectively (see Materials and Methods). Subsequently, I 
crossed the combined lines (lacI-GFP and MCP-RFP) with the one harbouring Adh-MS2 
construct. The best line for MCP-RFP among four (see Appendix III), were selected by their 
crossing with the Adh-MS2 reporter line. The salivary glands were inspected as before and 
the line which produced the strongest MCP-RFP signal, in correspondence to a single 
interband (which is more apparent upon ecdysone treatment and most probably corresponds 
to the nascent mRNA of the transgene) was selected (Figure 5.5 A).  Similarly, the best lacI-
GFP (among three lines, see Appendix III) lines were selected after crossing with Adh-ERE 
reporters carrying lacO repeats flanking the transcribed region and the promoter (see 
Appendix III).  The lacI-GFP lines are regulated by the heat shock promoter. Therefore, 
experiments were carried out with or without previous heat shock treatment. In the absence of 
heat shock, the signal is apparent at the transgene position (Figure 5.5 B, arrow). Upon heat 
shock, the signal becomes more prominent (Figure 5.5 C). The signal clearly located in the 
nucleus. These experiments demonstrated that the best lacI-GFP line is S-206, while the best 








Figure 5.5 Visualisation of the transgene using lacI-GFP. (A) Visualization of the Adh-MS2 
locus in salivary glands of flies expressing MCP-RFP (S-245, ID-9939, Appendix III).  Top left 
panel shows weak RFP signal in the nuclei of glands which were not incubated with ecdysone. 
Bottom panels show stronger RFP signal in glands incubated with ecdysone. RFP signal at the 
putative transgene locus is indicated by the arrow. (B) Control glands in which transgenes were 
carrying several lacO repeats (S-133, Appendix III) are visualised by crossing with lacI-GFP 
(S-206, Appendix III) without previously being heat shocked. (C) The same as in B except 
larvae were heat shocked prior dissection. Middle panels show DAPI staining, while right 
panel represents merged channel with DAPI. Micrographs were taken using an epifluorescence 




5.2.5 Simultaneous visualisation of nascent RNP and transgenic locus 
 
To verify that the MCP-RFP, reporting the nascent RNA, and lacI-GFP signal, reporting the 
Adh-MS2 transgene, are indeed co-localising, the strain carrying both lacI-GFP and MCP-
RFP was crossed with the Adh-MS2 reporter carrying strain (Figure 5.1). As expected, the 
prominent RFP and GFP signals co-localize in the nucleus (Figure 5.6, arrows). These results 
confirm that MS2-RNA signal we detect is in fact at the transgene.  Although both GFP and 
RFP fluorescence is visible throughout the nucleus, the signal is much stronger in 
correspondence to a single band. In summary, the results obtained so far make me confident 
that this system can be successfully used to investigate the docking of proteins on the spliced 








 Figure 5.6 Simultaneous visualization of the nascent RNA and the transgene locus  
Visualisation of both the transgene locus (the Adh-MS2 locus) and its nascent mRNA. LacI-
GFP signal corresponds to the locus (carrying lacO repeats), while MCP-RFP binds to the MS2 
repeats in the 3’UTR, therefore, MCP-RFP signal corresponds to the nascent RNA. Both GFP 
and RFP signals are detected at the same chromosomal site, denoted by an arrow. DAPI 
staining was also carried out in all samples in order to stain DNA. All images were taken using 




5.3 Discussion  
The physical coupling between transcription and pre-mRNA splicing has been shown to be 
important for accurate pre-mRNA splicing. The Pol II CTD may act as a platform for the 
localization of the splicing machinery near to the nascent transcript, as well as in helping define 
exons among intron sequences by exon tethering (Maniatis and Reed, 2002; Morris and 
Greenleaf, 2000). Here I reported that the MS2-GFP system is the most common in vivo 
approach to visualizing splicing and localization of mRNA in the cell. This system is based on 
the tethering of reporter mRNA with the MS2 sequence which is recognized by the GFP-
tagged MS2 coat protein. Therefore, it is feasible that reporter mRNA can be visualized in the 
cell by simultaneously expression of the MS2 coat protein tagged with either RFP or GFP 
(Martin et al., 2013; Querido and Chartrand, 2008). The transgenic construct I used allows 
detection of specific RNAs, and visualization of DNA loci. The observation from the first 
study, based on this principle, shows a strong, clear GFP signal in the nucleus, which 
corresponds to the (Adh-MS2) reporter. Although, by using this system also produced some 
background fluorescence, but the GFP signal is much stronger in corresponding of a single 
fluorescent dot. Therefore, this system allows visualization of nascent mRNA in the cell. The 
latter split Adh-MS2 reporter is more complex as it relies on pre-mRNA splicing of the reporter 
mRNA which produces a functional MS2 site only after splicing. Observation from my data 
indicates that it is feasible to visualize spliced mRNA, as a GFP signal was produced in the 
nucleus, corresponding to the split Adh-MS2 reporter. Therefore, this construct provides an 
effective model to visualize splicing and spliced mRNA at the same sites.  A key feature of all 
our reporter genes is that they are flanked by lacO repeats, which allows precise identification 
of the locus. Moreover, the reporter gene is also under the control of the ERE promoter, in 
which the signal becomes more apparent by treatment with ecdysone. To further verify the 
174 
 
GFP or RFP signal corresponds with the transgenic reporter locus would be required for 
independent identify the position the Adh-MS2 transgene in the intact nucleus, independent of 
the mRNP signal. To allow this, here I also produced a homozygous transgenic line, that 
expresses both lacI-GFP and MS2 coat protein MCP-RFP. The MCP-RFP will bind to the MS2 
site of the reporter mRNA, which produces the red fluorescence signal, and lacI-GFP will bind 
to the LacO repeats corresponding to the locus of Adh-MS2 reporter to give the green 
fluorescent signal. As expected, observations of both RFP signals and GFP signals in the 
nucleus suggest that the MS2-RNA signal corresponds to the transgenic construct. Based on 
the above results, here I visualized co-transcriptional splicing in Drosophila for the first time. 
By using this system, future studies should be able to investigate in detail how pre-mRNA 
decoration is affected by splicing signals. Unfortunately, due to time constraints, this last stage 
of the project could not be initiated, nor I could use this system to visualize how EJC proteins 
are recruited at transcription sites and nascent transcripts, or investigate the dependence of this 
recruitment on splicing features, such as the presence of introns or intron length. However, the 
procedure to complete the experiment may involve using both transgenic lines (intron-
containing and intron-less) and crosses with lacI-GFP lines (described above), then performing 
the double immunostaining in the polytene chromosome. The antibody against GFP will 
recognize the locus of the reporter transgene an antibody against the endogenous EJC protein 
allow us to detect whether the EJC signal is exactly at the same location as the GFP signal. If 
the EJC were to bind the transgene, this could provide further evidence that EJC recruitment is 





6.0 Discussion and Conclusion 
 
6.1 Association of eIF4AIII at transcription sites distinct to that of Y14 and MAGO 
 
Current models predict that the EJC binds an mRNA straight after pre-mRNA splicing 
(Kataoka et al., 2000; Le Hir et al., 2000a; Le Hir et al., 2000b). The EJC is best known for its 
role in NMD, but studies in yeast and Drosophila have concluded that it was not required for 
this process. However, EJC proteins are essential for survival in Drosophila and was known to 
be involved in mRNA localization. I wanted to understand how it performed this role and since 
it is a predominantly co-transcriptional process, I considered that a good starting point would 
be to visualise its recruitment at transcription sites of the Drosophila polytene chromosome. I 
also wanted to assess whether there are specific features of genes that promote EJC assembly.  
My data indicate that the EJC core components Y14, MAGO and eIF4AIII are in fact present 
at most transcription sites. Although in mammalian cells EJC core components are localized 
primarily in the nucleus (Baguet et al., 2007; Custodio et al., 2004), in Drosophila, these 
proteins seem to be equally distributed between the nucleus and the cytoplasm, as observed 
from nuclear and cytoplasmic fractionation of S2 cells. Thus the abundance of these proteins 
in the cytoplasm is in agreement with an earlier observation that EJC proteins, particularly 
the Y14/MAGO heterodimer, are required for localization of oskar mRNA during embryonic 
development in Drosophila (Hachet and Ephrussi, 2001). It was reported that Y14/MAGO 
formed a tight heterodimer, therefore these two proteins are expected to colocalize at the 
same position on the chromosome. As I have demonstrated from chromosome mapping, both 
Y14 and MAGO are in fact co-localized precisely at the same loci; this observation is further 
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verified by co-localization of Flag-Y14 with endogenous MAGO and is consistent with the 
earlier observation that these two protein form heterodimer. However, recruitment of 
eIF4AIII poorly correlates with Y14 and MAGO, as most of the transcription sites associated 
with eIF4AIII and this observation most apparent upon colocalization with active Poll II 
(PolI
Ser2
) – the antibody (H5) recognises the Ser2 hyperphosporylated CTD of the largest Pol 
II subunit, a marker of transcription elongation (Buratowski, 2009; O'Brien et al., 1994). 
Additionally, the observation that flag-tagged eIF4AIII is present at most transcription sites, 
and was not co-localized with Y14/MAGO, suggests that EJC assembly may not be a 
constitutive process in Drosophila.  All previous studies reported that EJCs assemble on 
maturing mRNAs during splicing, however, it was not clear how it makes contact with the 
spliceosome. However, it was recently suggested that one splicing factor, CWC22, interacts 
directly with eIF4AIII via its MIF4AG domain, which allows for the splicing-dependent 
assembly of EJCs (Alexandrov et al., 2012; Barbosa et al., 2012). Therefore, this raises the 
possibility that most of the transcription sites are associated with eIF4AIII and that this 
association is independent of Y14 and MAGO.   
6.1.1 MAGO is not essential for Y14 association with transcription sites  
 
Although knockdown of eIF4AIII impairs the development of salivary glands and polytene 
chromosomes could not be prepared from them, knockdown of either Y14 or MAGO does not 
have any phenotypic effects, allowing me to further investigate these proteins in this tissue. 
Interestingly, analysis of these glands indicates that Y14 does not require MAGO to associate 
with the transcription sites, however, MAGO knockdown reduced that of Y14 at the 
chromosomes. Although the Y14 signal was apparently reduced at the chromosomes, however, 
the staining pattern around the chromosome remain the same with typical interband staining as 
in wild type. This observation indicates an independent function of Y14 that does not require 
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MAGO to associate with the transcription sites. However, the reduced intensity of the Y14 
signal might solely be the result of the destabilization of the protein in the absence of MAGO.  
Additionally, it was recently reported that Y14 also functions as an inhibitor of mRNA 
decapping factor Dcp2 and modulates P body formation (Chuang et al., 2013). These 
observations are in further agreement with an earlier study that suggested Y14 functions in an 
independent manner that does not involve MAGO. To gain more detailed information about the 
role of their heterodimerization, I selectively knocked down Y14, MAGO and eIF4AIII in 
Drosophila S2 cells. Notably, and consistent with what was observed with the chromosome 
squashes, Y14 knockdown remarkably reduces MAGO recruitment and conversely, MAGO 
knockdown, reduces Y14, although not completely.  In both cases, eIF4AIII was not visibly 
affected by either Y14 or MAGO knockdown, as is consistent with the polytene chromosome 
staining. This observation suggests that Y14 and MAGO heterodimerization is required for the 
stability of both proteins in vivo. However, Y14/MAGO heterodimerization stabilizes both 
proteins, arguing that their function is coupled.  
6.1.2 The association of the EJC with transcription sites is splicing independent 
 
All current models predict that the EJC is at transcription sites because it binds to nascent 
mRNA or pre-mRNA (Custodio et al., 2004; Le Hir et al., 2000a). Notably, I found that 
following treatment with RNase, the EJC signal remain at transcription sites while the signals 
from Sm proteins and fluorouridine labelled nascent mRNA were completely diminished. 
Therefore, these observations suggest that the EJC core proteins possibly are not recruited to 
transcription sites by binding to nascent RNA, but might make RNA-independent secondary 
contacts with chromatin or DNA directly. To address EJC binding at transcription sites more 
specifically, we carried out ChIP followed by high throughput sequencing (ChIP-seq). ChIP-
seq of Y14 indicates that this protein mostly associates with transcription start sites and the 
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promoter region.  These observations suggest that Y14, either individually or as a part of the 
EJC, may have a specific role at the promoter region. Moreover, It has been reported by yeast 
two-hybrid screening that Y14 directly interact with signal transducer and activator of 
transcription 3 (STAT3) (Ohbayashi et al., 2008). STAT3 belongs to STAT protein family and 
function as a transcription factor. Therefore, enrichment of Y14 at promoter region might 
indicate their function related to transcription sites. It was recently reported that core EJC 
factors of the interact with SR proteins (Singh et al., 2012) particularly SRSF2, which is a part 
of the 7SK, a complex which activates transcription by binding promoter–proximal nascent 
RNA (Ji et al., 2013).  
So far, the pre-mRNA splicing is the only process that drives EJC with spliced mRNA. 
However, the recent finding concludes the function of pre-EJC that control the splicing of 
mapk and other long intron-containing genes which suggest that this complex has also a 
nuclear function (Ashton-Beaucage et al., 2010). It has been also proposed that knockdown of 
these proteins cause alternative splicing changes in mammalian cells (Wang et al., 2014). 
Therefore, these observations further raise the question of how does EJC core regulate splicing, 
given that it is deposited only after splicing? My data indicate that EJC core components are 
recruited to both intron-containing and intron-less genes. This is most apparent by the analysis 
of heat-shock puffs, which clearly show recruitment of EJC components at the intronless gene 
loci, 87A and 87C (encoding Hsp70), as well as at 93D which encodes the intron-containing, 
non-protein coding gene hsr-ω-n (Lakhotia and Tapadia, 1998). The Y14 ChIP-seq assay also 
shows enrichment independent of whether a gene has introns or not. The result from this study 
suggests that splicing is not a pre-requisite for binding of the EJC to transcription sites. Instead, 
my preliminary observations suggest a transcriptional role for EJC proteins. I observed that 
upon knockdown of Y14 and MAGO in S2 cells, the transcript levels of specific ecdysone 
inducible genes (75B) was significantly increased compared to the control. This raises the 
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possibility that Y14/MAGO might be function as transcriptional repressors of ecdysone-
induced genes.   
 
6.1.3 Nuclear translation visualized at transcription sites 
 
Although the EJC is not essential for NMD in Drosophila, it has recently been reported that 
some introns are able to trigger EJC dependent NMD in Drosophila (Sauliere et al., 2010). 
This observation is the first indication that EJC might have a role in NMD in Drosophila as 
well. Although NMD is a general phenomenon of cytoplasmic events, there is substantial 
evidence indicating that PTC recognition occurs on mRNAs while they are still in the 
nucleus. Observing that most transcription sites are associated with EJC, I applied a similar 
approach to visualize translation associated factors, ribosomal proteins, ribosomes and NMD 
factors at the same sites, since the ribosome is the only machinery able to scan the mRNA for 
a PTC during translation.  
 Ribosomal proteins, together with rRNA make up the large molecular machine that serves as 
the site of protein synthesis. Earlier evidence indicates that at least 20 RPs and rRNAs bind to 
transcription sites of Drosophila polytene chromosomes (Brogna et al., 2002). Analysis of 
several Drosophila endogenously YFP tagged ribosomal proteins, particularly RpL41, show 
strong accumulation both in the cytoplasm and nucleus. Additionally, native polytene 
chromosome staining further confirmed their association at transcription sites. This 
observation is consistent with the fact that fluorescently tagged ribosomal proteins are present 
at transcription sites in Drosophila polytene chromosomes (Rugjee et al., 2013). However, it 
was earlier reported that RPs have extra-ribosomal functions and some of the RPs regulate 
their own expression by binding to their pre-mRNA or promoters (Warner and McIntosh, 
2009). Therefore, observations of ribosomal proteins at transcription sites does not 
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necessarily confirm their presence as a complete ribosomal subunit at these sites. However, it 
might be that they are recruited at these sites as a complex, possibly ribosomal subunits, as 
previously proposed (Brogna et al., 2002; De et al., 2011). Additionally,  it was recently 
reported in yeast that it is possible that these RPs are in ribosomal subunits or other 
ribosomal-like complexes (De et al., 2011). 
To resolve the issue of whether there are functional ribosomes at transcription sites, I applied 
the ribopuromycylation technique (RPM) that was successfully developed to visualize 
puromycylated nascent peptides in HeLa cells (David et al., 2012). My observation that 
puromycin is incorporated at most transcription sites on the polytene chromosome along with 
other data we have published, strongly indicates the presence of translating 80S in the 
nucleolus and at transcription sites (Al-Jubran et al., 2013), it has been argued that 
puromycylation is an indicator of peptidyl transferase activity, but not necessarily of translation 
(Dahlberg and Lund, 2012). Whether RPM can be used to visualise translation needs to be 
further investigated. 
6.1.4 UPF1 recruitment at transcription sites indicates possible nuclear function 
 
Consistent with the view that translating ribosomes are present at transcription sites, in a 
parallel project during my PhD, I found that the NMD factor UPF1 binds to such sites. There 
is both direct and indirect evidence showing that proteins involved in NMD are at 
transcription sites. Additionally, whole salivary gland staining shows signal both in the 
cytoplasm and nucleus. Based on the current NMD model, unlike UPF3, UPF1 is a 
cytoplasmic protein and key component of NMD factor. However, from my data, association 
of UPF1 at the transcription sites might indicate possible nuclear function. This includes the 
observation that nonsense mutation are linked to abnormal polyadenylation of Adh pre-
mRNA in Drosophila (Brogna, 1999). Earlier studies also proposed that NMD thus occurs in 
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the nuclear fraction, or that the scanning of mRNAs occur while they are still associated with 
the nucleus before entering into the cytoplasm (Maquat and Carmichael, 2001; Urlaub et al., 
1989). A recent study in mammalian cells also reported enrichment of the NMD factor UPF1 
at transcription sites, further supporting the possibility of NMD occurring at the 
chromosomes. However, the association of UPF1 with these sites does not necessarily 
indicate the occurrence of NMD and therefore that translation is occurring there. There could 
be another function which is unrelated to NMD. Moreover, it has been also reported that 
UPF1 has a role in the replication of telomeres, which consequently aids in the stability of the 
genome (Azzalin, 2012). Therefore, it will be interesting to determine whether UPF1 
recruitment at transcription sites occurs either with nascent RNA, DNA or with other 
proteins. This is an aspect that should be investigated further in the future to better understand 
the function of UPF1 at the chromosomes.   
 
6.1.5 Transgenic reporter constructs provide an effective model to visualize splicing 
 
 The association of the EJC at transcription sites does not depend on the specific features of 
genes (intron-containing and intron-less), allowing me to further investigate its splicing 
independent association by using transgenic reporter constructs. In chapter five, I have 
described the experimental system that allows visualization of splicing at the transcription 
sites of Drosophila polytene chromosome. I have demonstrated that Adh-MS2 and a split 
Adh-MS2 reporter construct containing tagged with MS2 sequence and subsequently crossing 
with MCP-GFP or MCP-RFP lines is a preferable method to visualize nascent mRNA and 
splicing cotranscriptionally. Further, I also described a system that can be used to confirm 
that spliced or nascent MS2-mRNA corresponds to the transgenic reporter construct. MS2-
GFP system considered as an appropriate method to localize and detect the reporter mRNA in 
182 
 
the cell and was successfully applied before (Querido and Chartrand, 2008). However, due to 
time constraints, this last stage of the project could not be completed. Future works involve 
crossing the lacI GFP transgenic lines with both intron containing (Adh-MS2) and intron-less 
transgenic reporters (available in Dr. Brogna lab). In parallel, staining of EJC proteins will 
allow further investigation of the mechanism of splicing-independent EJC deposition. 
However, this system can also be used in the future to investigate how pre-mRNP decoration 
is affected by splicing signals or how EJC protein recruitment is affected due to specific 
features of genes such as long or short introns. 
 
6.2 Conclusion  
 
My data demonstrate that EJC proteins, particularly eIF4AIII, associate with most of the 
transcription sites. However, the association was observed at both intron-containing and 
intron-less genes on polytene chromosomes. The binding patterns of Y14 and MAGO are 
similar, yet apparently different from that of eIF4AIII. Additionally, the association of EJC 
proteins with transcription sites seems to be RNase-insensitive, and that of Y14/MAGO 
shows no correlation with splicing markers or with nascent RNA. Chromatin 
immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) indicates that the 
association of EJC protein peaks at transcription start sites in Drosophila cells. These 
observations are inconsistent both with constitutive splicing-dependent EJC deposition and 
with eIF4AII forming a stable complex with Y14 and MAGO in Drosophila; instead they 
suggest that eIF4AIII and Y14/MAGO have separate splicing-independent roles at 
transcription sites. Consistent with this prediction, RNAi of Y14/MAGO altered transcription 
induction of ecdysone responsive genes. My study also demonstrates that there are ribosomal 
proteins and functional ribosome at transcription sites, which further indicates translation 
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might be occurring at these sites. Although it is not clear yet whether translation at this sites 
produces functional proteins, will be an interesting question to investigate in future. I also 
observed that UPF1 is recruited at most of the transcription sites, suggesting that NMD can 
occur co-transcriptionally. Moreover, the MS2-GFP system I have described also can be used 
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Protocol for ChIP 
 
1. Grow the S2 cells in a complete medium for two days to get a 10x10
6
 cells. 
2. Started with 10x10
6
 S2 cells. 
3. Mix, and add formaldehyde (10%) to 1%  v/v final concentration. 
4. Incubate at 25⁰C for 15 minutes. 
5. Add glycine to 125mM and mix incubate 5 min at 25°C. 
6. Centrifuge 3000 rpm/ 835 g (Eppendorf) 5 min at 4°C in a benchtop centrifuge 
7. Remove supernatant. 
8. Resuspend in 500 µl of 1X PBS + 1X Protease inhibitors (Roche EDTA free mini protease 
inhibitor). 
9. Repeat 2X. 
10. Remove supernatant and store as cell pellet at -80⁰C. 
11. The day before the ChIP prepare antibody coated Dynal beads (Protein-G for rabbit IgG). 
Resuspend beads by gentle vortexing. Per ChIP prepares 40 µl of beads. Split into two tubes, 
25 µl for ChIP (+Ab) and 15 µl for pre-absorb (-Ab). Wash beads in a low-bind tube 4x with 
1 ml of 1XPBS, 5mg/ml BSA. Wash the beads in a magnetic rack by moving 6 times each. 
Pull-down beads using magnetic rack and discard supernatant completely. 
12. After the final wash resuspend the beads in 500 all of 1XPBS, 5mg/ml BSA. Leave 
Pre-absorb (-Ab) beads as its. To antibody coated beads add at least 2 µg of antibody. 




14. On the day of the ChIP. Thaw cells on ice. Resuspend cell pellets in 100 µl 
Of  SDS Lysis Buffer. Sonicate at high intensity for 12 min with 15 Sec on/off. 
15. Dilute sample to 1 ml using ChIP dilution buffer. 
16. Centrifuge at 13000 rpm/ 15682 g (Eppendorf) for 10 minutes in a microcentrifuge at 
18°C (NB. SDS will precipitate at 4⁰C) to the pellet insoluble material. 
17. Remove supernatant to a fresh DNA lobind tube. 
18. While sonication is being performed, wash ChIP (+Ab), and pre-absorb (-Ab) beads. 
Pellet in a magnetic rack and wash with 1 ml of 1XPBS, 5mg/ml BSA 4 times to remove 
unbound antibody. During the wash mix it properly by vortex and spin briefly. Resuspend 
beads finally in 40 µl  of 1 ml of 1XPBS, 5mg/ml BSA. 
19. Pre-absorb (-Ab) beads slurry resuspend in a 25 µl of 1 ml of 1XPBS, 5mg/ml BSA. And 
add to the soluble chromatin prepared in 17. 
20. Incubate 15 min at R.T by using a rotating rotator. 
21. Spin briefly and Pellet beads using magnetic rack and transfer cleared supernatant to a 
fresh lobind tube. 
22. Remove 100 µl of soluble chromatin from 21 to use as input sample. Reserve in a lobind 
tube in -20°C. 
23. To remaining chromatin add   40 µl ChIP (+Ab) bead slurry from step 18. 
24. Incubate 2.30 hrs at room temperature, on a rotator to form immune complexes on beads. 
25. Spin briefly and Pull-down beads on magnetic rack and discard supernatant. 
26. Wash 5 minutes each on rotating rotor at R.T with 1 ml of the following. During the wash 
mix it properly by vortex and spin briefly. Wash the beads in a magnetic rack by moving 6 
times each and discard the supernatant. 
26.1 Low salt wash-1x 
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26.2 High salt wash-1x 
26.3 LiCl wash-1x 
27. Then wash twice with 1 ml of TE buffer. 
28. Elute protein-DNA complexes by two washes with 75 µl of freshly prepared 
1% v/v SDS 0.1M NaHC03 solution. Vortex, spin and then incubate  at RT in a rotating rotor 
for 15 min. Spin briefly and put on magnetic rack, transfer the supernatant on to new lobind 
tubes. Repeat the above process again with 75 µl of elution buffer so the total volume at the 
end 150 µl. 
29. Combine the elutes. 
30. To the input DNA reserved in step 22 add 50 µl of elution buffer (28) to make an equal 
volume with chip sample (150 µl). 
31. Add protease K to all samples (2 µl of 50 mg/ml) including input and Chip sample and 
incubate at 65⁰C on the dry heat block overnight to digest protein and reverse crosslinks. 
32. The following morning purifies DNA using AMPure XP beads (both the input and chip 
sample). Basically add 1.8volumes of AMPure XP bead slurry to DNA. Mix it properly by 
vortexing. Allow Bind for 10 minutes in rotating rotor at RT, spin briefly and then pellet 
beads in a magnetic rack and discard the supernatant. Wash 3X with 300 µl of freshly 
prepared 70% v/v ethanol, each time vortex, spin it puts on magnetic rack and rotate 6 times 
and discard the supernatant. After the final wash, spin it again and put on a magnetic rack to 
make sure there is no ethanol. Air-dry in the magnetic stand until the beads are dry and show 
visible cracking. Elute DNA using 30 µl of 10 mM Tris (8.0). Transfer elute 3 times into new 
lobind tubes by placing in magnetic rack to remove magnetic beads completely. 




Standard Protocol for Salivary glands squashing and immunostaining 
 
1. D. melaonogaster larvae were grown at 18⁰C in bottles containing dry yeast. 
2. Larvae were collected from bottles and placed in a dissecting glass dish filled with water to 
wash and put them on ice to sleep for 5 minutes. 
3. Larvae were then dissected in a dissection buffer of 20μl solutions A, using sharp tweezers. 
For the fixation, salivary glands were transferred in a 20μl of solution B and kept for 1 
minute. 
4. Salivary glands were washed in 20μl solutions G for a few seconds and then transfer to 
siliconized glass coverslip containing 13μl solutions G. Glands were allowed to incubate in 
solution G for 3 minutes. 
5. After that frozen end microscopic slide touch on the top of the coverslip and make sure that 
liquid evenly spread throughout the coverslip and slide. 
6. Salivary glands were first spread with the blunt tip of the brush by tapping a few times on 
top of the coverslip. After that folded tissue paper kept on top of coverslip and squashed 
vertically using the thumb. 
7. Check the spreading of the polytene chromosome by placing under the phase contrast 
microscope. 
8. The position of the coverslip marked by diamond pencil on both sides of the coverslip and 
the sample were freeze on the slide by dipping into liquid nitrogen for 60 seconds. 
198 
 
9. Coverslip were removed from the slide using a razor blade and then put in a coplin jar 
filled with 95% ethanol and stored at -20°C for next day immunostaining. 
10. Next day polytene chromosome spread slides were first washed in a coplin jar with 1X 
TBST (150 Mm NaCl, 10 mM Tris-Cl pH 7.0-7.5, 0.05% v/v Tween) two times for 10 
minutes each at room temperature. 
11.Slides were transferred in a coplin jar filled with blocking solution TBS, 10% Fetal 
Bovine Serum (FBS) and 0.05% v/w sodium azide (NaN3) for 30 minutes at room 
temperature. 
12. Primary antibody diluted (1: 100, depend on the concentration of antibody) with blocking 
solution and proceed for immunostaining. 
13. 20μl drops of diluted antibody put on the coverslip and the slides were touch on top of the 
drop carefully make sure there was no air bubbles between the slide and coverslip. 
14. Humid chamber was made by TBS and slides were then placed in a humid chamber and 
incubate overnight at 4⁰C. 
15. Next day morning slides were removed from the chamber and placed in a beaker with 
TBST to displace the coverslip from slide. Slides were then washed with TBST two times 10 
minutes each at room temperature. 
16. Secondary antibody staining was carried out in a same way as primary antibody but the 
dilution of secondary antibody was (1: 250) with blocking solution and incubated at room 
temperature for 1 hour in a humid chamber. 
17. Slides were first washed with TBST containing DAPI (1: 10,000 dilutions) 0.1 μg /ml to 
stain DNA followed by a second wash with TBST for 10 minutes. 
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18. Slides were dried in a room temperature about 20 minutes, and covered with aluminium 
foil to protect from light. 
19. Once the slides were dried out, a drop of mountaining medium were places on the 
coverslip and carefully touch with the dried slides on top of mountaining medium. 





List of Primers 
 



































































































S 86 RpL41 
Forward 
CTAAATGCACAGCGACGGAT 

























List of Fly stocks 
 
ID name  Lines Origin 
FKH- GAL4  Fork head -GAL4 Brogna Lab 
Double Balancer stock  
  
w+;  IF; MKRS  
        Cyo; TM6B 
Hidalgo Lab 
S-240  
MCP-GFP , ID-7278 
P{w[+mC]=Hsp83-MCP-
GFP}11, y[1] w[*] 
Bloomington Drosophila 
















Stock Center  
S-243 





Stock Center  














































































eIF4AIII/TM3 C-terminal 2X 







eIF4AIII/TM3 C-terminal 2X 












Y14 RNAi, ID-36024 
 (w1118; P{GD14025}v36024)  
 




 (P{KK101462}VIE-260B ) 
 
VDRC RNAi stock centre 
S-252 
 Mago RNAi, ID-
28132 
w[1118]; P{GD12556}v28132  
 
VDRC RNAi stock centre 
S-305 
Y14 RNAi, ID-36585 




Stock Center  
S-306 
Mago RNAi, ID-35453 













S-308 UPF1 RNAi, ID 
43144 





 Stock Center 
lac O (S-133) P [W
+
= Lac O repeat] (E2)
  
 Brogna Lab 
lac I-GFP (S-205) 6(4.1)/CyO hsp83::Gfp-lacI J.Vasquez 
Lac I-GFP (S-206) 6(4:1)/ Cyo hsp83.GFP-lac I J.Vasquez 
MIN-4 (S-118) ERE-Adh1-MS2 Brogna Lab 





Appendix IV      
List of plasmid  
 
Name Description Origin 
UPF1-GFP (B 306) pAGW.N-termGFP.UPF1 Brogna lab 
FLAG/HA-Y14 pUAST-attB-Y14-2XHF Marco Blanchette 




Appendix V    
DNA sequencing and BLAT search were matched with tagging construct of RpL41-YFP 
and RpL10Ab-YFP and RpS9-YFP (034) 
 



























































 None of the UPF2 monoclonal antibodies could recognize UPF2 protein by Western   
blotting 
 
The 15 ascites samples corresponding to hybridoma against the 12 UPF2 epitopes (see 
Appendix VII (B) for the list of all ascites and clone ID number) were tested by Western 
blotting as before. Unlike for the UPF1 antibodies, none of the ascites samples detected a 
band of the size expected for UPF2, and some give extensive background (see figure below). 
All clones were renamed to distinguish from each other like UPF1 based on their lane 
number in Western blot from UPF2-1 to UPF2-15. It was therefore decided not to proceed 


















Western blot of S2 cell extract to test the specificity of each clone correspond to 
endogenous UPF2   
(A) & (B) S2 cell extract immunoblot with UPF2-1 to UPF2-15 ascites, in which none of the 
clones able to detect the right molecular size (140.08 kDa) against the endogenous UPF2. All 




(A) List of UPF1 Ascites 
Project ID Target 
protein 








Ascites Abmart Inc 



































Ascites Abmart Inc 





Ascites Abmart Inc 



































































(B) List of UPF2 Ascites 
 
Project ID Target 
protein 








Ascites Abmart Inc 



































Ascites Abmart Inc 





Ascites Abmart Inc 





























Ascites Abmart Inc 
















Appendix VIII      
Y14 ChIP-seq genes list (top 20 based on their Wig peak height) 
 
flanking genes within 300bp upstream 
and downstream 
 























Appendix IX   
Published articles 
1. Rugjee, K.N., Roy Chaudhury, S., Al-Jubran, K., Ramanathan, P., Matina, T., Wen, J., and 
Brogna, S. (2013). Fluorescent protein tagging confirms the presence of ribosomal proteins at 
Drosophila polytene chromosomes. PeerJ 1, e15. 
2. Al-Jubran, K., Wen, J., Abdullahi, A., Roy Chaudhury, S., Li, M., Ramanathan, P.,    
Matina, A., De, S., Piechocki, K., Rugjee, K.N., et al. (2013). Visualization of the joining of   
ribosomal subunits reveals the presence of 80S ribosomes in the nucleus. RNA 19, 1669-
1683. 
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